> top > docs > PMC:7295011 > annotations

PMC:7295011 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T1 28-35 SO:0000704 denotes Genetic
T2 48-52 G_3;PG_10;PR:000003622 denotes ACE2
T3 57-64 G_2;PR:000016456 denotes TMPRSS2
T4 65-70 SO:0000704 denotes Genes
T5 83-93 SP_7 denotes SARS-CoV-2
T6 108-113 SP_6;NCBITaxon:9606 denotes Human
T7 148-159 NCBITaxon:11118 denotes Coronavirus
T8 174-182 SP_7 denotes COVID-19
T9 210-220 GO:0010467 denotes expression
T10 346-357 UBERON:0001004 denotes respiratory
T11 386-391 GO:0016265 denotes death
T12 567-577 SP_7 denotes SARS-CoV-2
T13 578-583 NCBITaxon:10239 denotes virus
T14 629-634 SP_6;NCBITaxon:9606 denotes human
T15 635-640 SO:0000704 denotes genes
T16 646-651 SP_6;NCBITaxon:9606 denotes human
T17 661-692 PG_10;PR:000003622 denotes angiotensin converting enzyme 2
T18 694-698 G_3;PG_10;PR:000003622 denotes ACE2
T19 704-717 GO:0042148 denotes cell invasion
T20 743-750 G_2;PR:000016456 denotes TMPRSS2
T21 755-764 PG_1 denotes S protein
T22 774-781 SO:0000704 denotes Genetic
T23 805-810 SO:0000704 denotes genes
T24 820-828 GO:0065007 denotes modulate
T25 832-842 NCBITaxon:1 denotes individual
T26 845-852 SO:0000704 denotes genetic
T27 885-890 NCBITaxon:10239 denotes virus
T28 908-915 SO:0000704 denotes genetic
T29 924-932 SP_7 denotes COVID-19
T30 1050-1055 SO:0000704 denotes genes
T31 1065-1070 SP_6;NCBITaxon:9606 denotes human
T32 1180-1189 GO:0008152 denotes metabolic
T33 1317-1324 SO:0000704 denotes genetic
T34 1353-1357 G_3;PG_10;PR:000003622 denotes ACE2
T35 1362-1369 G_2 denotes TMPRSS2
T36 1492-1523 SO:0000694 denotes single nucleotide polymorphisms
T37 1525-1529 SO:0000694 denotes SNPs
T38 1540-1547 G_2;PR:000016456 denotes TMPRSS2
T39 1548-1553 SO:0000704 denotes genes
T40 1612-1616 SO:0000694 denotes SNPs
T41 1628-1632 G_3;PG_10;PR:000003622 denotes ACE2
T42 1633-1637 SO:0000704 denotes gene
T43 1674-1688 DG_37 denotes angiotensin II
T44 1855-1862 CHEBI:35341;CHEBI:35341 denotes steroid
T45 1863-1880 CHEBI:67079;CHEBI:67079 denotes anti-inflammatory
T46 2167-2175 SP_7 denotes COVID-19
T47 2214-2221 SO:0000704 denotes genetic
T48 2249-2257 SP_7 denotes COVID-19
T49 2363-2378 SP_7 denotes covid19research
T50 2424-2435 NCBITaxon:11118 denotes coronavirus
T51 2450-2458 SP_7 denotes COVID-19
T52 2474-2484 SP_7 denotes SARS-CoV-2
T53 2485-2490 NCBITaxon:10239 denotes virus
T54 2564-2572 SP_7 denotes COVID-19
T55 2627-2633 NCBITaxon:9606 denotes people
T56 2677-2688 UBERON:0001004 denotes respiratory
T57 2914-2925 UBERON:0001004 denotes respiratory
T58 3278-3286 SP_7 denotes COVID-19
T59 3492-3502 SP_7 denotes SARS-CoV-2
T60 3521-3532 NCBITaxon:1 denotes individuals
T61 3578-3584 UBERON:0002405;GO:0006955 denotes immune
T62 3585-3593 GO:0006955 denotes response
T63 3675-3683 SP_7 denotes COVID-19
T64 3723-3734 NCBITaxon:1 denotes individuals
T65 3812-3820 SP_7 denotes COVID-19
T66 3910-3918 SP_7 denotes COVID-19
T67 4022-4026 CHEBI:23888;CHEBI:23888 denotes drug
T68 4072-4082 SP_7 denotes SARS-CoV-2
T69 4116-4126 SP_7 denotes SARS-CoV-2
T70 4147-4155 SP_7 denotes COVID-19
T71 4199-4206 SO:0000704 denotes genetic
T72 4252-4259 SO:0000704 denotes genetic
T73 4271-4279 SP_7 denotes COVID-19
T74 4379-4387 SP_7 denotes COVID-19
T75 4432-4441 SP_7 denotes covid19hg
T76 4493-4500 SO:0000704 denotes genetic
T77 4513-4518 SO:0000704 denotes genes
T78 4531-4541 SP_7 denotes SARS-CoV-2
T79 4555-4560 SP_6;NCBITaxon:9606 denotes human
T80 4757-4764 SO:0000704 denotes genetic
T81 4779-4787 GO:0065007 denotes modulate
T82 4918-4925 SO:0000704 denotes genetic
T83 4942-4948 PR:000004690 denotes BCL11A
T84 4949-4953 SO:0000704 denotes gene
T85 4973-4979 SO:0001026 denotes genome
T86 5108-5115 SO:0000704 denotes genetic
T87 5152-5160 GO:0065007 denotes modulate
T88 5198-5209 CL:0000740 denotes sickle cell
T89 5299-5310 NCBITaxon:1 denotes individuals
T90 5456-5461 CHEBI:23888;CHEBI:23888 denotes drugs
T91 5500-5507 SO:0000704 denotes genetic
T92 5520-5525 SO:0000704 denotes genes
T93 5540-5550 SP_7 denotes SARS-CoV-2
T94 5564-5569 SP_6;NCBITaxon:9606 denotes human
T95 5687-5695 SP_7 denotes COVID-19
T96 5789-5799 SP_7 denotes SARS-CoV-2
T97 5863-5894 PG_10;PR:000003622 denotes Angiotensin converting enzyme 2
T98 5896-5900 G_3;PG_10;PR:000003622 denotes ACE2
T99 5939-5944 NCBITaxon:10239 denotes virus
T100 5972-5977 NCBITaxon:10239 denotes viral
T101 6002-6015 GO:0016020 denotes transmembrane
T102 6016-6033 PR:000027796 denotes Serine Protease 2
T103 6035-6042 G_2;PR:000016456 denotes TMPRSS2
T104 6098-6103 NCBITaxon:10239 denotes viral
T105 6147-6151 G_3;PG_10;PR:000003622 denotes ACE2
T106 6204-6211 SO:0000704 denotes genetic
T107 6232-6239 G_2;PR:000016456 denotes TMPRSS2
T108 6305-6313 UBERON:0002367 denotes prostate
T109 6424-6428 G_3;PG_10;PR:000003622 denotes ACE2
T110 6480-6484 G_3;PG_10;PR:000003622 denotes ACE2
T111 6485-6489 SO:0000704 denotes gene
T112 6508-6520 GO:0000805 denotes X chromosome
T113 6536-6542 SO:0001026 denotes genome
T114 6585-6591 SO:0001026 denotes genome
T115 6673-6682 GO:0030849 denotes autosomal
T116 6724-6729 SP_6;NCBITaxon:9606 denotes human
T117 6746-6750 G_3;PG_10;PR:000003622 denotes ACE2
T118 6825-6832 SO:0000704 denotes genetic
T119 6867-6871 G_3;PG_10;PR:000003622 denotes ACE2
T120 6876-6883 G_2;PR:000016456 denotes TMPRSS2
T121 6884-6895 SO:0000673 denotes transcripts
T122 7084-7088 CHEBI:23888;CHEBI:23888 denotes drug
T123 7147-7153 UBERON:0001969 denotes plasma
T124 7192-7203 NCBITaxon:1 denotes individuals
T125 7297-7301 UBERON:0002048 denotes lung
T126 7311-7317 UBERON:0002113 denotes kidney
T127 7334-7340 UBERON:0002405 denotes immune
T128 7353-7362 GO:0008152 denotes metabolic
T129 7582-7590 GO:0065007 denotes modulate
T130 7591-7601 SP_7 denotes SARS-CoV-2
T131 7637-7646 UBERON:0000104 denotes Lifelines
T132 7658-7667 UBERON:0000104 denotes Lifelines
T133 7875-7886 NCBITaxon:1 denotes individuals
T134 8154-8163 UBERON:0000104 denotes Lifelines
T135 9120-9132 GO:0000805 denotes X chromosome
T136 9430-9445 SP_7 denotes covid19research
T137 9539-9548 GO:0030849 denotes autosomal
T138 9553-9565 GO:0000805 denotes X-chromosome
T139 9653-9662 SO:0001024 denotes Haplotype
T140 9842-9848 SO:0001023 denotes allele
T141 9968-9979 NCBITaxon:1 denotes individuals
T142 10494-10500 UBERON:0001969 denotes plasma
T143 10508-10522 UBERON:0004535 denotes cardiovascular
T144 10648-10654 UBERON:0001969 denotes plasma
T145 10655-10665 CHEBI:18211;CHEBI:18211 denotes citrulline
T146 10846-10850 CHEBI:23888;CHEBI:23888 denotes drug
T147 11114-11124 UBERON:0001062 denotes anatomical
T148 11227-11231 CHEBI:23888;CHEBI:23888 denotes drug
T149 11356-11360 CHEBI:23888;CHEBI:23888 denotes drug
T150 11638-11650 GO:0000805 denotes X chromosome
T151 11735-11742 SO:0000704 denotes genetic
T152 11778-11782 G_3;PG_10;PR:000003622 denotes ACE2
T153 11824-11831 G_2;PR:000016456 denotes TMPRSS2
T154 11870-11881 SO:0000673 denotes transcripts
T155 11897-11928 SO:0000694 denotes single-nucleotide polymorphisms
T156 11930-11934 SO:0000694 denotes SNPs
T157 11947-11953 SO:0001023 denotes allele
T158 12204-12208 CHEBI:23888;CHEBI:23888 denotes Drug
T159 12330-12337 SO:0000704 denotes genetic
T160 12794-12801 SO:0000704 denotes genetic
T161 13089-13093 G_3;PG_10;PR:000003622 denotes ACE2
T162 13098-13105 G_2;PR:000016456 denotes TMPRSS2
T163 13988-13992 G_3;PG_10;PR:000003622 denotes ACE2
T164 13997-14004 G_2;PR:000016456 denotes TMPRSS2
T165 14030-14036 SO:0001026 denotes genome
T166 14111-14117 SO:0001023 denotes allele
T167 14163-14169 SO:0001023 denotes allele
T168 14188-14194 SO:0001023 denotes allele
T169 14216-14222 SO:0001023 denotes allele
T170 14258-14269 CL:0000771 denotes Eosinophils
T171 14276-14289 CHEBI:17855;CHEBI:17855 denotes triglycerides
T172 14291-14296 PR:000005426 denotes CHIT1
T173 14298-14304 UBERON:0001969 denotes plasma
T174 14315-14320 PR:000005426 denotes CHIT1
T175 14334-14346 CL:0000351 denotes thrombocytes
T176 14367-14373 UBERON:0001969 denotes plasma
T177 14445-14456 NCBITaxon:1 denotes individuals
T178 14827-14834 SO:0000704 denotes genetic
T179 15146-15158 SO:0000704 denotes GeneticPower
T180 15665-15671 SO:0001023 denotes allele
T181 15803-15807 CHEBI:23888;CHEBI:23888 denotes drug
T182 16249-16256 SO:0000704 denotes genetic
T183 16289-16293 G_3;PG_10;PR:000003622 denotes ACE2
T184 16298-16305 G_2;PR:000016456 denotes TMPRSS2
T185 16306-16317 SO:0000673 denotes transcripts
T186 16425-16431 SO:0001026 denotes genome
T187 16592-16596 G_3;PG_10;PR:000003622 denotes ACE2
T188 16613-16626 CHEBI:17855;CHEBI:17855 denotes triglycerides
T189 16668-16678 CL:0000771 denotes eosinophil
T190 16771-16778 G_2;PR:000016456 denotes TMPRSS2
T191 16795-16801 UBERON:0001969 denotes plasma
T192 16812-16817 PR:000005426 denotes CHIT1
T193 16955-16968 CHEBI:17855;CHEBI:17855 denotes triglycerides
T194 16972-16976 G_3;PG_10;PR:000003622 denotes ACE2
T195 17330-17333 SO:0000694 denotes SNP
T196 17571-17576 PR:000005426 denotes CHIT1
T197 17577-17583 UBERON:0001969 denotes plasma
T198 17693-17697 G_3;PG_10;PR:000003622 denotes ACE2
T199 17764-17768 G_3;PG_10;PR:000003622 denotes ACE2
T200 17783-17786 SO:0000694 denotes SNP
T201 17888-17895 SO:0000704 denotes genetic
T202 17998-18005 SO:0001026 denotes genomic
T203 18035-18042 SO:0001026 denotes genomic
T204 18269-18276 SO:0001026 denotes Genomes
T205 18506-18511 SO:0000704 denotes genes
T206 18543-18548 SO:0000147 denotes exons
T207 18694-18701 G_2;PR:000016456 denotes TMPRSS2
T208 18768-18775 G_2;PR:000016456 denotes TMPRSS2
T209 18790-18793 SO:0000694 denotes SNP
T210 18895-18902 SO:0000704 denotes genetic
T211 19004-19011 SO:0001026 denotes genomic
T212 19041-19048 SO:0001026 denotes genomic
T213 19275-19282 SO:0001026 denotes Genomes
T214 19533-19541 UBERON:0002367 denotes prostate
T215 19585-19590 SO:0000704 denotes genes
T216 19622-19627 SO:0000147 denotes exons
T217 19858-19865 SO:0000704 denotes genetic
T218 19882-19888 SO:0001026 denotes genome
T219 19984-19988 G_3;PG_10;PR:000003622 denotes ACE2
T220 20026-20031 CHEBI:23888;CHEBI:23888 denotes drugs
T221 20050-20057 CHEBI:35341;CHEBI:35341 denotes steroid
T222 20058-20075 CHEBI:67079;CHEBI:67079 denotes anti-inflammatory
T223 20104-20110 CHEBI:35472;CHEBI:35472 denotes NSAIDs
T224 20197-20203 SO:0001023 denotes allele
T225 20272-20286 DG_37 denotes angiotensin II
T226 20338-20354 CHEBI:67079;CHEBI:67079 denotes antihypertensive
T227 20355-20360 CHEBI:23888;CHEBI:23888 denotes drugs
T228 20432-20438 SO:0001023 denotes allele
T229 20481-20485 SO:0000694 denotes SNPs
T230 20506-20512 SO:0000188 denotes intron
T231 20526-20530 G_3;PG_10;PR:000003622 denotes ACE2
T232 20531-20541 SO:0000673 denotes transcript
T233 20555-20557 SO:0000028 denotes bp
T234 20628-20635 SO:0001026 denotes Genomes
T235 20711-20715 G_3;PG_10;PR:000003622 denotes ACE2
T236 20720-20727 G_2;PR:000016456 denotes TMPRSS2
T237 21621-21625 CHEBI:23888;CHEBI:23888 denotes drug
T238 21661-21665 G_3;PG_10;PR:000003622 denotes ACE2
T239 21670-21677 G_2;PR:000016456 denotes TMPRSS2
T240 21703-21709 SO:0001026 denotes genome
T241 21766-21772 SO:0001023 denotes allele
T242 21789-21795 SO:0001023 denotes allele
T243 21814-21820 SO:0001023 denotes allele
T244 21842-21848 SO:0001023 denotes allele
T245 21932-21940 CHEBI:35341;CHEBI:35341 denotes steroids
T246 21948-21962 CHEBI:48432;CHEBI:48432;DG_37 denotes Angiotensin II
T247 22009-22021 CHEBI:35718;CHEBI:35718 denotes Antimycotics
T248 22046-22061 CHEBI:50858;CHEBI:50858 denotes Corticosteroids
T249 22070-22076 CHEBI:35472;CHEBI:35472 denotes NSAIDs
T250 22141-22150 CHEBI:5855;CHEBI:5855 denotes ibuprofen
T251 22340-22345 CHEBI:23888;CHEBI:23888 denotes drugs
T252 22457-22462 CHEBI:23888;CHEBI:23888 denotes drugs
T253 22622-22633 NCBITaxon:1 denotes individuals
T254 22658-22664 SO:0001023 denotes allele
T255 22754-22765 NCBITaxon:1 denotes individuals
T256 22781-22787 SO:0001023 denotes allele
T257 22808-22811 SO:0000694 denotes SNP
T258 22864-22870 GO:0007631 denotes intake
T259 22968-22979 NCBITaxon:1 denotes individuals
T260 23034-23045 SO:0000704 denotes genetically
T261 23546-23552 SO:0001026 denotes genome
T262 23689-23696 G_2;PR:000016456 denotes TMPRSS2
T263 23734-23739 CHEBI:23888;CHEBI:23888 denotes drugs
T264 23751-23763 CHEBI:35718;CHEBI:35718 denotes antimycotics
T265 23817-23832 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T266 24001-24005 SO:0000694 denotes SNPs
T267 24308-24312 CHEBI:23888;CHEBI:23888 denotes drug
T268 24346-24357 CHEBI:23888;CHEBI:23888 denotes medications
T269 24550-24561 CHEBI:24271;CHEBI:24271 denotes glucosamine
T270 24652-24663 CHEBI:3347;CHEBI:3347 denotes candesartan
T271 24664-24673 CHEBI:23243;CHEBI:23243 denotes cilexetin
T272 25047-25056 UBERON:0000104 denotes Lifelines
T273 25204-25214 SP_7 denotes SARS-CoV-2
T274 25220-25224 G_3;PG_10;PR:000003622 denotes ACE2
T275 25289-25293 G_3;PG_10;PR:000003622 denotes ACE2
T276 25303-25316 GO:0042148 denotes cell invasion
T277 25332-25339 G_2;PR:000016456 denotes TMPRSS2
T278 25340-25350 GO:0010467 denotes expression
T279 25376-25383 SO:0000704 denotes Genetic
T280 25408-25413 SO:0000704 denotes genes
T281 25438-25442 SO:0000704 denotes gene
T282 25504-25514 SP_7 denotes SARS-CoV-2
T283 25534-25542 SP_7 denotes COVID-19
T284 25578-25585 SO:0000704 denotes genetic
T285 25600-25605 SP_6;NCBITaxon:9606 denotes human
T286 25712-25723 NCBITaxon:1 denotes individuals
T287 25757-25768 NCBITaxon:1 denotes individuals
T288 25778-25787 UBERON:0000104 denotes Lifelines
T289 25878-25883 SO:0000704 denotes genes
T290 25946-25950 UBERON:0002048 denotes lung
T291 25960-25966 UBERON:0002113 denotes kidney
T292 25983-25989 UBERON:0002405 denotes immune
T293 26002-26011 GO:0008152 denotes metabolic
T294 26240-26253 CHEBI:17855;CHEBI:17855 denotes triglycerides
T295 26293-26307 UBERON:0004535 denotes cardiovascular
T296 26356-26364 SP_7 denotes COVID-19
T297 26415-26422 SO:0000704 denotes genetic
T298 26560-26570 GO:0065007 denotes regulation
T299 26574-26582 SP_7 denotes COVID-19
T300 26643-26649 UBERON:0002405;CL:0000738 denotes immune
T301 26650-26654 CL:0000738 denotes cell
T302 26744-26751 SO:0000704 denotes genetic
T303 26916-26920 G_3;PG_10;PR:000003622 denotes ACE2
T304 27016-27029 CHEBI:35472;CHEBI:35472 denotes -inflammatory
T305 27034-27053 CHEBI:35842;CHEBI:35842 denotes antirheumatic drugs
T306 27055-27061 CHEBI:35472;CHEBI:35472 denotes NSAIDs
T307 27164-27171 G_2;PR:000016456 denotes TMPRSS2
T308 27302-27308 CHEBI:35472;CHEBI:35472 denotes NSAIDs
T309 27322-27330 SP_7 denotes COVID-19
T310 27440-27444 G_3;PG_10;PR:000003622 denotes ACE2
T311 27445-27455 GO:0010467 denotes expression
T312 27520-27525 UBERON:0000178 denotes blood
T313 27628-27633 CHEBI:23888;CHEBI:23888 denotes drugs
T314 27717-27722 UBERON:0000178 denotes blood
T315 27928-27932 CHEBI:23888;CHEBI:23888 denotes drug
T316 28030-28037 SO:0000704 denotes genetic
T317 28178-28182 G_3;PG_10;PR:000003622 denotes ACE2
T318 28374-28378 SO:0000694 denotes SNPs
T319 28620-28626 SO:0001026 denotes genome
T320 28775-28784 CHEBI:35222;CHEBI:35222 denotes inhibitor
T321 28861-28865 CHEBI:23888;CHEBI:23888 denotes drug
T322 28950-28959 CHEBI:35222;CHEBI:35222 denotes inhibitor
T323 29036-29039 SO:0000694 denotes SNP
T324 29109-29120 NCBITaxon:1 denotes individuals
T325 29170-29176 SO:0001023 denotes allele
T326 29324-29332 SO:0001026 denotes Genomes1
T327 29350-29356 SO:0001023 denotes allele
T328 29374-29377 SO:0000694 denotes SNP
T329 29419-29425 CHEBI:35472;CHEBI:35472 denotes NSAIDs
T330 29624-29632 SO:0001026 denotes Genomes1
T331 29683-29689 CHEBI:35472;CHEBI:35472 denotes NSAIDs
T332 29771-29782 NCBITaxon:1 denotes individuals
T333 29813-29818 CHEBI:23888;CHEBI:23888 denotes drugs
T334 29914-29922 SP_7 denotes COVID-19
T335 29981-29987 SO:0001023 denotes allele
T336 30099-30107 SP_7 denotes COVID-19
T337 30256-30263 SO:0000704 denotes genetic
T338 30301-30311 SP_7 denotes SARS-CoV-2
T339 30330-30338 SP_7 denotes COVID-19
T340 30381-30387 CHEBI:35472;CHEBI:35472 denotes NSAIDs
T341 30406-30414 SP_7 denotes COVID-19
T342 30744-30748 CHEBI:23888;CHEBI:23888 denotes drug
T343 30935-30946 NCBITaxon:1 denotes individuals
T344 31366-31374 SP_7 denotes COVID-19
T345 31539-31546 SO:0000704 denotes genetic
T346 31604-31608 G_3;PG_10;PR:000003622 denotes ACE2
T347 31613-31620 G_2;PR:000016456 denotes TMPRSS2
T348 31621-31626 SO:0000704 denotes genes
T349 31670-31675 SP_6;NCBITaxon:9606 denotes human
T350 31736-31743 SO:0000704 denotes Genetic
T351 31866-31873 SO:0000704 denotes genetic
T352 31893-31898 SO:0000704 denotes genes
T353 31930-31940 GO:0065007 denotes regulating
T354 31945-31958 UBERON:0002405 denotes immune system
T355 31999-32009 SP_7 denotes SARS-CoV-2
T356 32059-32066 SO:0000704 denotes genetic
T357 32088-32096 SP_7 denotes COVID-19
T358 32127-32135 SP_7 denotes COVID-19
T359 32180-32189 SP_7 denotes covid19hg
T360 32232-32240 SP_7 denotes COVID-19
T361 32272-32279 SO:0001026 denotes genomes
T362 32631-32646 SP_7 denotes covid19research
T363 32691-32696 SP_6;NCBITaxon:9606 denotes human
T364 33166-33175 UBERON:0000104 denotes Lifelines
T365 33380-33389 UBERON:0000104 denotes Lifelines
T15389 28-35 SO:0000704 denotes Genetic
T95515 48-52 G_3;PG_10;PR:000003622 denotes ACE2
T46443 57-64 G_2;PR:000016456 denotes TMPRSS2
T6164 65-70 SO:0000704 denotes Genes
T29313 83-93 SP_7 denotes SARS-CoV-2
T65028 108-113 SP_6;NCBITaxon:9606 denotes Human
T82605 148-159 NCBITaxon:11118 denotes Coronavirus
T63788 174-182 SP_7 denotes COVID-19
T90963 210-220 GO:0010467 denotes expression
T98467 346-357 UBERON:0001004 denotes respiratory
T74990 386-391 GO:0016265 denotes death
T77048 567-577 SP_7 denotes SARS-CoV-2
T63906 578-583 NCBITaxon:10239 denotes virus
T38650 629-634 SP_6;NCBITaxon:9606 denotes human
T66707 635-640 SO:0000704 denotes genes
T91998 646-651 SP_6;NCBITaxon:9606 denotes human
T46823 661-692 PG_10;PR:000003622 denotes angiotensin converting enzyme 2
T3987 694-698 G_3;PG_10;PR:000003622 denotes ACE2
T78675 704-717 GO:0042148 denotes cell invasion
T45453 743-750 G_2;PR:000016456 denotes TMPRSS2
T6888 755-764 PG_1 denotes S protein
T17243 774-781 SO:0000704 denotes Genetic
T60656 805-810 SO:0000704 denotes genes
T1259 820-828 GO:0065007 denotes modulate
T79081 832-842 NCBITaxon:1 denotes individual
T30784 845-852 SO:0000704 denotes genetic
T12440 885-890 NCBITaxon:10239 denotes virus
T93273 908-915 SO:0000704 denotes genetic
T11884 924-932 SP_7 denotes COVID-19
T27369 1050-1055 SO:0000704 denotes genes
T38320 1065-1070 SP_6;NCBITaxon:9606 denotes human
T48900 1180-1189 GO:0008152 denotes metabolic
T21768 1317-1324 SO:0000704 denotes genetic
T58706 1353-1357 G_3;PG_10;PR:000003622 denotes ACE2
T58032 1362-1369 G_2 denotes TMPRSS2
T36127 1492-1523 SO:0000694 denotes single nucleotide polymorphisms
T82637 1525-1529 SO:0000694 denotes SNPs
T2971 1540-1547 G_2;PR:000016456 denotes TMPRSS2
T7106 1548-1553 SO:0000704 denotes genes
T47131 1612-1616 SO:0000694 denotes SNPs
T41549 1628-1632 G_3;PG_10;PR:000003622 denotes ACE2
T21285 1633-1637 SO:0000704 denotes gene
T45074 1674-1688 DG_37 denotes angiotensin II
T48118 1855-1862 CHEBI:35341;CHEBI:35341 denotes steroid
T4305 1863-1880 CHEBI:67079;CHEBI:67079 denotes anti-inflammatory
T10485 2167-2175 SP_7 denotes COVID-19
T71331 2214-2221 SO:0000704 denotes genetic
T63391 2249-2257 SP_7 denotes COVID-19
T96456 2363-2378 SP_7 denotes covid19research
T79046 2424-2435 NCBITaxon:11118 denotes coronavirus
T44764 2450-2458 SP_7 denotes COVID-19
T91417 2474-2484 SP_7 denotes SARS-CoV-2
T5564 2485-2490 NCBITaxon:10239 denotes virus
T86160 2564-2572 SP_7 denotes COVID-19
T74218 2627-2633 NCBITaxon:9606 denotes people
T24341 2677-2688 UBERON:0001004 denotes respiratory
T53581 2914-2925 UBERON:0001004 denotes respiratory
T64178 3278-3286 SP_7 denotes COVID-19
T51772 3492-3502 SP_7 denotes SARS-CoV-2
T7882 3521-3532 NCBITaxon:1 denotes individuals
T86501 3578-3584 UBERON:0002405;GO:0006955 denotes immune
T42303 3585-3593 GO:0006955 denotes response
T97056 3675-3683 SP_7 denotes COVID-19
T52643 3723-3734 NCBITaxon:1 denotes individuals
T74044 3812-3820 SP_7 denotes COVID-19
T21732 3910-3918 SP_7 denotes COVID-19
T85539 4022-4026 CHEBI:23888;CHEBI:23888 denotes drug
T7516 4072-4082 SP_7 denotes SARS-CoV-2
T11848 4116-4126 SP_7 denotes SARS-CoV-2
T55584 4147-4155 SP_7 denotes COVID-19
T9234 4199-4206 SO:0000704 denotes genetic
T35285 4252-4259 SO:0000704 denotes genetic
T29085 4271-4279 SP_7 denotes COVID-19
T88607 4379-4387 SP_7 denotes COVID-19
T26301 4432-4441 SP_7 denotes covid19hg
T7265 4493-4500 SO:0000704 denotes genetic
T77494 4513-4518 SO:0000704 denotes genes
T95690 4531-4541 SP_7 denotes SARS-CoV-2
T30166 4555-4560 SP_6;NCBITaxon:9606 denotes human
T98319 4757-4764 SO:0000704 denotes genetic
T46219 4779-4787 GO:0065007 denotes modulate
T31772 4918-4925 SO:0000704 denotes genetic
T50101 4942-4948 PR:000004690 denotes BCL11A
T63374 4949-4953 SO:0000704 denotes gene
T29873 4973-4979 SO:0001026 denotes genome
T83318 5108-5115 SO:0000704 denotes genetic
T2944 5152-5160 GO:0065007 denotes modulate
T77581 5198-5209 CL:0000740 denotes sickle cell
T96342 5299-5310 NCBITaxon:1 denotes individuals
T33095 5456-5461 CHEBI:23888;CHEBI:23888 denotes drugs
T29932 5500-5507 SO:0000704 denotes genetic
T97601 5520-5525 SO:0000704 denotes genes
T62271 5540-5550 SP_7 denotes SARS-CoV-2
T22191 5564-5569 SP_6;NCBITaxon:9606 denotes human
T56651 5687-5695 SP_7 denotes COVID-19
T26486 5789-5799 SP_7 denotes SARS-CoV-2
T90039 5863-5894 PG_10;PR:000003622 denotes Angiotensin converting enzyme 2
T71262 5896-5900 G_3;PG_10;PR:000003622 denotes ACE2
T68336 5939-5944 NCBITaxon:10239 denotes virus
T75908 5972-5977 NCBITaxon:10239 denotes viral
T97330 6002-6015 GO:0016020 denotes transmembrane
T93942 6016-6033 PR:000027796 denotes Serine Protease 2
T44333 6035-6042 G_2;PR:000016456 denotes TMPRSS2
T44532 6098-6103 NCBITaxon:10239 denotes viral
T61217 6147-6151 G_3;PG_10;PR:000003622 denotes ACE2
T28029 6204-6211 SO:0000704 denotes genetic
T26789 6232-6239 G_2;PR:000016456 denotes TMPRSS2
T94688 6305-6313 UBERON:0002367 denotes prostate
T12498 6424-6428 G_3;PG_10;PR:000003622 denotes ACE2
T72212 6480-6484 G_3;PG_10;PR:000003622 denotes ACE2
T46681 6485-6489 SO:0000704 denotes gene
T84878 6508-6520 GO:0000805 denotes X chromosome
T9958 6536-6542 SO:0001026 denotes genome
T24857 6585-6591 SO:0001026 denotes genome
T29326 6673-6682 GO:0030849 denotes autosomal
T51651 6724-6729 SP_6;NCBITaxon:9606 denotes human
T58959 6746-6750 G_3;PG_10;PR:000003622 denotes ACE2
T14387 6825-6832 SO:0000704 denotes genetic
T67688 6867-6871 G_3;PG_10;PR:000003622 denotes ACE2
T44105 6876-6883 G_2;PR:000016456 denotes TMPRSS2
T21420 6884-6895 SO:0000673 denotes transcripts
T52763 7084-7088 CHEBI:23888;CHEBI:23888 denotes drug
T44636 7147-7153 UBERON:0001969 denotes plasma
T96363 7192-7203 NCBITaxon:1 denotes individuals
T83611 7297-7301 UBERON:0002048 denotes lung
T41395 7311-7317 UBERON:0002113 denotes kidney
T8593 7334-7340 UBERON:0002405 denotes immune
T79776 7353-7362 GO:0008152 denotes metabolic
T19292 7582-7590 GO:0065007 denotes modulate
T31649 7591-7601 SP_7 denotes SARS-CoV-2
T92197 7637-7646 UBERON:0000104 denotes Lifelines
T28417 7658-7667 UBERON:0000104 denotes Lifelines
T34463 7875-7886 NCBITaxon:1 denotes individuals
T76810 8154-8163 UBERON:0000104 denotes Lifelines
T88244 9120-9132 GO:0000805 denotes X chromosome
T60022 9430-9445 SP_7 denotes covid19research
T78088 9539-9548 GO:0030849 denotes autosomal
T4295 9553-9565 GO:0000805 denotes X-chromosome
T94950 9653-9662 SO:0001024 denotes Haplotype
T92138 9842-9848 SO:0001023 denotes allele
T80908 9968-9979 NCBITaxon:1 denotes individuals
T4591 10494-10500 UBERON:0001969 denotes plasma
T32427 10508-10522 UBERON:0004535 denotes cardiovascular
T87048 10648-10654 UBERON:0001969 denotes plasma
T42051 10655-10665 CHEBI:18211;CHEBI:18211 denotes citrulline
T72423 10846-10850 CHEBI:23888;CHEBI:23888 denotes drug
T50135 11114-11124 UBERON:0001062 denotes anatomical
T47265 11227-11231 CHEBI:23888;CHEBI:23888 denotes drug
T61766 11356-11360 CHEBI:23888;CHEBI:23888 denotes drug
T2343 11638-11650 GO:0000805 denotes X chromosome
T25187 11735-11742 SO:0000704 denotes genetic
T48627 11778-11782 G_3;PG_10;PR:000003622 denotes ACE2
T58131 11824-11831 G_2;PR:000016456 denotes TMPRSS2
T58183 11870-11881 SO:0000673 denotes transcripts
T65079 11897-11928 SO:0000694 denotes single-nucleotide polymorphisms
T8518 11930-11934 SO:0000694 denotes SNPs
T63813 11947-11953 SO:0001023 denotes allele
T76985 12204-12208 CHEBI:23888;CHEBI:23888 denotes Drug
T93194 12330-12337 SO:0000704 denotes genetic
T25280 12794-12801 SO:0000704 denotes genetic
T76647 13089-13093 G_3;PG_10;PR:000003622 denotes ACE2
T51606 13098-13105 G_2;PR:000016456 denotes TMPRSS2
T84210 13988-13992 G_3;PG_10;PR:000003622 denotes ACE2
T94818 13997-14004 G_2;PR:000016456 denotes TMPRSS2
T47033 14030-14036 SO:0001026 denotes genome
T11053 14111-14117 SO:0001023 denotes allele
T11793 14163-14169 SO:0001023 denotes allele
T67851 14188-14194 SO:0001023 denotes allele
T29785 14216-14222 SO:0001023 denotes allele
T50211 14258-14269 CL:0000771 denotes Eosinophils
T39248 14276-14289 CHEBI:17855;CHEBI:17855 denotes triglycerides
T76881 14291-14296 PR:000005426 denotes CHIT1
T65791 14298-14304 UBERON:0001969 denotes plasma
T33478 14315-14320 PR:000005426 denotes CHIT1
T47666 14334-14346 CL:0000351 denotes thrombocytes
T1982 14367-14373 UBERON:0001969 denotes plasma
T8692 14445-14456 NCBITaxon:1 denotes individuals
T98782 14827-14834 SO:0000704 denotes genetic
T37248 15146-15158 SO:0000704 denotes GeneticPower
T90943 15665-15671 SO:0001023 denotes allele
T67682 15803-15807 CHEBI:23888;CHEBI:23888 denotes drug
T43362 16249-16256 SO:0000704 denotes genetic
T77072 16289-16293 G_3;PG_10;PR:000003622 denotes ACE2
T94059 16298-16305 G_2;PR:000016456 denotes TMPRSS2
T39099 16306-16317 SO:0000673 denotes transcripts
T9066 16425-16431 SO:0001026 denotes genome
T76644 16592-16596 G_3;PG_10;PR:000003622 denotes ACE2
T19158 16613-16626 CHEBI:17855;CHEBI:17855 denotes triglycerides
T16016 16668-16678 CL:0000771 denotes eosinophil
T19017 16771-16778 G_2;PR:000016456 denotes TMPRSS2
T34658 16795-16801 UBERON:0001969 denotes plasma
T57879 16812-16817 PR:000005426 denotes CHIT1
T84412 16955-16968 CHEBI:17855;CHEBI:17855 denotes triglycerides
T8943 16972-16976 G_3;PG_10;PR:000003622 denotes ACE2
T57096 17330-17333 SO:0000694 denotes SNP
T77216 17571-17576 PR:000005426 denotes CHIT1
T71259 17577-17583 UBERON:0001969 denotes plasma
T58601 17693-17697 G_3;PG_10;PR:000003622 denotes ACE2
T5927 17764-17768 G_3;PG_10;PR:000003622 denotes ACE2
T39562 17783-17786 SO:0000694 denotes SNP
T57069 17888-17895 SO:0000704 denotes genetic
T61081 17998-18005 SO:0001026 denotes genomic
T23543 18035-18042 SO:0001026 denotes genomic
T99812 18269-18276 SO:0001026 denotes Genomes
T1458 18506-18511 SO:0000704 denotes genes
T24028 18543-18548 SO:0000147 denotes exons
T95895 18694-18701 G_2;PR:000016456 denotes TMPRSS2
T72558 18768-18775 G_2;PR:000016456 denotes TMPRSS2
T1892 18790-18793 SO:0000694 denotes SNP
T28060 18895-18902 SO:0000704 denotes genetic
T18775 19004-19011 SO:0001026 denotes genomic
T80366 19041-19048 SO:0001026 denotes genomic
T79819 19275-19282 SO:0001026 denotes Genomes
T82679 19533-19541 UBERON:0002367 denotes prostate
T29382 19585-19590 SO:0000704 denotes genes
T88473 19622-19627 SO:0000147 denotes exons
T40837 19858-19865 SO:0000704 denotes genetic
T22364 19882-19888 SO:0001026 denotes genome
T20938 19984-19988 G_3;PG_10;PR:000003622 denotes ACE2
T95863 20026-20031 CHEBI:23888;CHEBI:23888 denotes drugs
T89900 20050-20057 CHEBI:35341;CHEBI:35341 denotes steroid
T61584 20058-20075 CHEBI:67079;CHEBI:67079 denotes anti-inflammatory
T34216 20104-20110 CHEBI:35472;CHEBI:35472 denotes NSAIDs
T59194 20197-20203 SO:0001023 denotes allele
T27712 20272-20286 DG_37 denotes angiotensin II
T35154 20338-20354 CHEBI:67079;CHEBI:67079 denotes antihypertensive
T58579 20355-20360 CHEBI:23888;CHEBI:23888 denotes drugs
T78381 20432-20438 SO:0001023 denotes allele
T42486 20481-20485 SO:0000694 denotes SNPs
T62742 20506-20512 SO:0000188 denotes intron
T69433 20526-20530 G_3;PG_10;PR:000003622 denotes ACE2
T88777 20531-20541 SO:0000673 denotes transcript
T23755 20555-20557 SO:0000028 denotes bp
T7551 20628-20635 SO:0001026 denotes Genomes
T30648 20711-20715 G_3;PG_10;PR:000003622 denotes ACE2
T56311 20720-20727 G_2;PR:000016456 denotes TMPRSS2
T17596 21621-21625 CHEBI:23888;CHEBI:23888 denotes drug
T92322 21661-21665 G_3;PG_10;PR:000003622 denotes ACE2
T86076 21670-21677 G_2;PR:000016456 denotes TMPRSS2
T20826 21703-21709 SO:0001026 denotes genome
T63926 21766-21772 SO:0001023 denotes allele
T99021 21789-21795 SO:0001023 denotes allele
T1597 21814-21820 SO:0001023 denotes allele
T6875 21842-21848 SO:0001023 denotes allele
T36626 21932-21940 CHEBI:35341;CHEBI:35341 denotes steroids
T33146 21948-21962 CHEBI:48432;CHEBI:48432;DG_37 denotes Angiotensin II
T54324 22009-22021 CHEBI:35718;CHEBI:35718 denotes Antimycotics
T46939 22046-22061 CHEBI:50858;CHEBI:50858 denotes Corticosteroids
T66398 22070-22076 CHEBI:35472;CHEBI:35472 denotes NSAIDs
T95707 22141-22150 CHEBI:5855;CHEBI:5855 denotes ibuprofen
T70106 22340-22345 CHEBI:23888;CHEBI:23888 denotes drugs
T35557 22457-22462 CHEBI:23888;CHEBI:23888 denotes drugs
T35953 22622-22633 NCBITaxon:1 denotes individuals
T44828 22658-22664 SO:0001023 denotes allele
T74453 22754-22765 NCBITaxon:1 denotes individuals
T1159 22781-22787 SO:0001023 denotes allele
T24605 22808-22811 SO:0000694 denotes SNP
T46742 22864-22870 GO:0007631 denotes intake
T40982 22968-22979 NCBITaxon:1 denotes individuals
T51604 23034-23045 SO:0000704 denotes genetically
T43243 23546-23552 SO:0001026 denotes genome
T87256 23689-23696 G_2;PR:000016456 denotes TMPRSS2
T56525 23734-23739 CHEBI:23888;CHEBI:23888 denotes drugs
T44205 23751-23763 CHEBI:35718;CHEBI:35718 denotes antimycotics
T39655 23817-23832 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T63158 24001-24005 SO:0000694 denotes SNPs
T13338 24308-24312 CHEBI:23888;CHEBI:23888 denotes drug
T46377 24346-24357 CHEBI:23888;CHEBI:23888 denotes medications
T54174 24550-24561 CHEBI:24271;CHEBI:24271 denotes glucosamine
T3707 24652-24663 CHEBI:3347;CHEBI:3347 denotes candesartan
T22655 24664-24673 CHEBI:23243;CHEBI:23243 denotes cilexetin
T40791 25047-25056 UBERON:0000104 denotes Lifelines
T73832 25204-25214 SP_7 denotes SARS-CoV-2
T90063 25220-25224 G_3;PG_10;PR:000003622 denotes ACE2
T80854 25289-25293 G_3;PG_10;PR:000003622 denotes ACE2
T84726 25303-25316 GO:0042148 denotes cell invasion
T38598 25332-25339 G_2;PR:000016456 denotes TMPRSS2
T75228 25340-25350 GO:0010467 denotes expression
T30453 25376-25383 SO:0000704 denotes Genetic
T91525 25408-25413 SO:0000704 denotes genes
T39790 25438-25442 SO:0000704 denotes gene
T50047 25504-25514 SP_7 denotes SARS-CoV-2
T85509 25534-25542 SP_7 denotes COVID-19
T18375 25578-25585 SO:0000704 denotes genetic
T53098 25600-25605 SP_6;NCBITaxon:9606 denotes human
T43469 25712-25723 NCBITaxon:1 denotes individuals
T45629 25757-25768 NCBITaxon:1 denotes individuals
T18820 25778-25787 UBERON:0000104 denotes Lifelines
T59723 25878-25883 SO:0000704 denotes genes
T27361 25946-25950 UBERON:0002048 denotes lung
T30026 25960-25966 UBERON:0002113 denotes kidney
T31433 25983-25989 UBERON:0002405 denotes immune
T52456 26002-26011 GO:0008152 denotes metabolic
T21130 26240-26253 CHEBI:17855;CHEBI:17855 denotes triglycerides
T46118 26293-26307 UBERON:0004535 denotes cardiovascular
T32927 26356-26364 SP_7 denotes COVID-19
T13810 26415-26422 SO:0000704 denotes genetic
T74912 26560-26570 GO:0065007 denotes regulation
T89207 26574-26582 SP_7 denotes COVID-19
T29316 26643-26649 UBERON:0002405;CL:0000738 denotes immune
T62697 26650-26654 CL:0000738 denotes cell
T83862 26744-26751 SO:0000704 denotes genetic
T79097 26916-26920 G_3;PG_10;PR:000003622 denotes ACE2
T80863 27016-27029 CHEBI:35472;CHEBI:35472 denotes -inflammatory
T87460 27034-27053 CHEBI:35842;CHEBI:35842 denotes antirheumatic drugs
T30538 27055-27061 CHEBI:35472;CHEBI:35472 denotes NSAIDs
T5988 27164-27171 G_2;PR:000016456 denotes TMPRSS2
T92623 27302-27308 CHEBI:35472;CHEBI:35472 denotes NSAIDs
T85324 27322-27330 SP_7 denotes COVID-19
T24262 27440-27444 G_3;PG_10;PR:000003622 denotes ACE2
T5745 27445-27455 GO:0010467 denotes expression
T88744 27520-27525 UBERON:0000178 denotes blood
T26802 27628-27633 CHEBI:23888;CHEBI:23888 denotes drugs
T62915 27717-27722 UBERON:0000178 denotes blood
T75656 27928-27932 CHEBI:23888;CHEBI:23888 denotes drug
T11372 28030-28037 SO:0000704 denotes genetic
T52756 28178-28182 G_3;PG_10;PR:000003622 denotes ACE2
T91710 28374-28378 SO:0000694 denotes SNPs
T12343 28620-28626 SO:0001026 denotes genome
T37453 28775-28784 CHEBI:35222;CHEBI:35222 denotes inhibitor
T69178 28861-28865 CHEBI:23888;CHEBI:23888 denotes drug
T80076 28950-28959 CHEBI:35222;CHEBI:35222 denotes inhibitor
T83680 29036-29039 SO:0000694 denotes SNP
T36304 29109-29120 NCBITaxon:1 denotes individuals
T63848 29170-29176 SO:0001023 denotes allele
T1008 29324-29332 SO:0001026 denotes Genomes1
T74496 29350-29356 SO:0001023 denotes allele
T63175 29374-29377 SO:0000694 denotes SNP
T16369 29419-29425 CHEBI:35472;CHEBI:35472 denotes NSAIDs
T43926 29624-29632 SO:0001026 denotes Genomes1
T95358 29683-29689 CHEBI:35472;CHEBI:35472 denotes NSAIDs
T59775 29771-29782 NCBITaxon:1 denotes individuals
T94552 29813-29818 CHEBI:23888;CHEBI:23888 denotes drugs
T80695 29914-29922 SP_7 denotes COVID-19
T21332 29981-29987 SO:0001023 denotes allele
T99280 30099-30107 SP_7 denotes COVID-19
T91239 30256-30263 SO:0000704 denotes genetic
T28392 30301-30311 SP_7 denotes SARS-CoV-2
T91349 30330-30338 SP_7 denotes COVID-19
T14747 30381-30387 CHEBI:35472;CHEBI:35472 denotes NSAIDs
T90587 30406-30414 SP_7 denotes COVID-19
T48752 30744-30748 CHEBI:23888;CHEBI:23888 denotes drug
T47008 30935-30946 NCBITaxon:1 denotes individuals
T80878 31366-31374 SP_7 denotes COVID-19
T75823 31539-31546 SO:0000704 denotes genetic
T93647 31604-31608 G_3;PG_10;PR:000003622 denotes ACE2
T13697 31613-31620 G_2;PR:000016456 denotes TMPRSS2
T36059 31621-31626 SO:0000704 denotes genes
T17625 31670-31675 SP_6;NCBITaxon:9606 denotes human
T75793 31736-31743 SO:0000704 denotes Genetic
T18635 31866-31873 SO:0000704 denotes genetic
T10910 31893-31898 SO:0000704 denotes genes
T4622 31930-31940 GO:0065007 denotes regulating
T34234 31945-31958 UBERON:0002405 denotes immune system
T34031 31999-32009 SP_7 denotes SARS-CoV-2
T22485 32059-32066 SO:0000704 denotes genetic
T33974 32088-32096 SP_7 denotes COVID-19
T9063 32127-32135 SP_7 denotes COVID-19
T74444 32180-32189 SP_7 denotes covid19hg
T64859 32232-32240 SP_7 denotes COVID-19
T25606 32272-32279 SO:0001026 denotes genomes
T67381 32631-32646 SP_7 denotes covid19research
T14036 32691-32696 SP_6;NCBITaxon:9606 denotes human
T23759 33166-33175 UBERON:0000104 denotes Lifelines
T68140 33380-33389 UBERON:0000104 denotes Lifelines

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 704-708 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T2 727-733 Body_part denotes serine http://purl.org/sig/ont/fma/fma82764
T3 757-764 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T4 1159-1168 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T5 1499-1509 Body_part denotes nucleotide http://purl.org/sig/ont/fma/fma82740
T6 1575-1587 Body_part denotes thrombocytes http://purl.org/sig/ont/fma/fma62851
T7 1633-1637 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T8 4949-4953 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T9 4973-4979 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T10 5021-5031 Body_part denotes hemoglobin http://purl.org/sig/ont/fma/fma62293
T11 5205-5209 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T12 5959-5963 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T13 5984-5992 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T14 6016-6022 Body_part denotes Serine http://purl.org/sig/ont/fma/fma82764
T15 6110-6118 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T16 6134-6138 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T17 6252-6262 Body_part denotes chromosome http://purl.org/sig/ont/fma/fma67093
T18 6305-6313 Body_part denotes prostate http://purl.org/sig/ont/fma/fma9600
T19 6485-6489 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T20 6508-6520 Body_part denotes X chromosome http://purl.org/sig/ont/fma/fma84055
T21 6536-6542 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T22 6585-6591 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T23 6673-6682 Body_part denotes autosomal http://purl.org/sig/ont/fma/fma74406
T24 6683-6694 Body_part denotes chromosomes http://purl.org/sig/ont/fma/fma67093
T25 7129-7136 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T26 7147-7153 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T27 7162-7171 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T28 7297-7301 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T29 7311-7317 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T30 9120-9132 Body_part denotes X chromosome http://purl.org/sig/ont/fma/fma84055
T31 9539-9548 Body_part denotes autosomal http://purl.org/sig/ont/fma/fma74406
T32 9553-9565 Body_part denotes X-chromosome http://purl.org/sig/ont/fma/fma84055
T33 10278-10281 Body_part denotes MAP http://purl.org/sig/ont/fma/fma67847
T34 10476-10483 Body_part denotes Protein http://purl.org/sig/ont/fma/fma67257
T35 10494-10500 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T36 10531-10539 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T37 10648-10654 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T38 10670-10679 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T39 11638-11650 Body_part denotes X chromosome http://purl.org/sig/ont/fma/fma84055
T40 11904-11914 Body_part denotes nucleotide http://purl.org/sig/ont/fma/fma82740
T41 13120-13124 Body_part denotes Gene http://purl.org/sig/ont/fma/fma74402
T42 14030-14036 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T43 14258-14269 Body_part denotes Eosinophils http://purl.org/sig/ont/fma/fma62861
T44 14298-14304 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T45 14321-14328 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T46 14334-14346 Body_part denotes thrombocytes http://purl.org/sig/ont/fma/fma62851
T47 14367-14373 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T48 14374-14382 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T49 14390-14399 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T50 16425-16431 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T51 16668-16678 Body_part denotes eosinophil http://purl.org/sig/ont/fma/fma62861
T52 16795-16801 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T53 16852-16864 Body_part denotes thrombocytes http://purl.org/sig/ont/fma/fma62851
T54 17577-17583 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T55 17984-17988 Body_part denotes axis http://purl.org/sig/ont/fma/fma12520
T56 18052-18056 Body_part denotes axis http://purl.org/sig/ont/fma/fma12520
T57 18269-18276 Body_part denotes Genomes http://purl.org/sig/ont/fma/fma84116
T58 18990-18994 Body_part denotes axis http://purl.org/sig/ont/fma/fma12520
T59 19058-19062 Body_part denotes axis http://purl.org/sig/ont/fma/fma12520
T60 19275-19282 Body_part denotes Genomes http://purl.org/sig/ont/fma/fma84116
T61 19533-19541 Body_part denotes prostate http://purl.org/sig/ont/fma/fma9600
T62 19882-19888 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T63 20506-20512 Body_part denotes intron http://purl.org/sig/ont/fma/fma84121
T64 20628-20635 Body_part denotes Genomes http://purl.org/sig/ont/fma/fma84116
T65 20750-20754 Body_part denotes Gene http://purl.org/sig/ont/fma/fma74402
T66 21703-21709 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T67 23546-23552 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T68 24550-24561 Body_part denotes glucosamine http://purl.org/sig/ont/fma/fma82797
T69 25255-25260 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T70 25303-25307 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T71 25438-25442 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T72 25946-25950 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T73 25960-25966 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T74 26258-26270 Body_part denotes thrombocytes http://purl.org/sig/ont/fma/fma62851
T75 26650-26654 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T76 26664-26672 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T77 27520-27525 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T78 27717-27722 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T79 28620-28626 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T80 31945-31958 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T81 32272-32279 Body_part denotes genomes http://purl.org/sig/ont/fma/fma84116
T82 33023-33025 Body_part denotes AG http://purl.org/sig/ont/fma/fma61898
T83 33062-33064 Body_part denotes AG http://purl.org/sig/ont/fma/fma61898
T84 33066-33068 Body_part denotes PL http://purl.org/sig/ont/fma/fma273007
T85 33242-33244 Body_part denotes AG http://purl.org/sig/ont/fma/fma61898
T86 33305-33307 Body_part denotes PL http://purl.org/sig/ont/fma/fma273007
T87 34721-34728 Body_part denotes Genomes http://purl.org/sig/ont/fma/fma84116
T88 35613-35618 Body_part denotes Organ http://purl.org/sig/ont/fma/fma67498
T89 35672-35677 Body_part denotes Heart http://purl.org/sig/ont/fma/fma7088
T90 35947-35952 Body_part denotes Heart http://purl.org/sig/ont/fma/fma7088
T91 36610-36614 Body_part denotes axis http://purl.org/sig/ont/fma/fma12520
T92 36735-36739 Body_part denotes axis http://purl.org/sig/ont/fma/fma12520
T93 36853-36857 Body_part denotes axis http://purl.org/sig/ont/fma/fma12520
T94 37007-37011 Body_part denotes axis http://purl.org/sig/ont/fma/fma12520
T95 37125-37129 Body_part denotes axis http://purl.org/sig/ont/fma/fma12520

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 4246-4251 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542
T2 6579-6584 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542
T3 7297-7301 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T4 7311-7317 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T5 25946-25950 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T6 25960-25966 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T7 27520-27525 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T8 27717-27722 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T9 30484-30488 Body_part denotes Gill http://purl.obolibrary.org/obo/UBERON_0002535
T10 31945-31958 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T11 32053-32058 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542
T12 35613-35618 Body_part denotes Organ http://purl.obolibrary.org/obo/UBERON_0000062
T13 35672-35677 Body_part denotes Heart http://purl.obolibrary.org/obo/UBERON_0000948
T14 35947-35952 Body_part denotes Heart http://purl.obolibrary.org/obo/UBERON_0000948

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id tao:has_standard_notation
4 48-52 Gene denotes ACE2 Gene:59272
5 57-64 Gene denotes TMPRSS2 Gene:7113
6 108-113 Species denotes Human Tax:9606
7 83-103 Disease denotes SARS-CoV-2 Infection MESH:C000657245
35 661-692 Gene denotes angiotensin converting enzyme 2 Gene:59272
36 694-698 Gene denotes ACE2 Gene:59272
37 743-750 Gene denotes TMPRSS2 Gene:7113
38 1353-1357 Gene denotes ACE2 Gene:59272
39 1362-1369 Gene denotes TMPRSS2 Gene:7113
40 1540-1547 Gene denotes TMPRSS2 Gene:7113
41 1628-1632 Gene denotes ACE2 Gene:59272
42 567-577 Species denotes SARS-CoV-2 Tax:2697049
43 629-634 Species denotes human Tax:9606
44 646-651 Species denotes human Tax:9606
45 933-941 Species denotes patients Tax:9606
46 1065-1070 Species denotes human Tax:9606
47 727-733 Chemical denotes serine MESH:D012694
48 1855-1862 Chemical denotes steroid MESH:D013256
49 148-172 Disease denotes Coronavirus disease 2019 MESH:C000657245
50 174-182 Disease denotes COVID-19 MESH:C000657245
51 329-338 Disease denotes pneumonia MESH:D011014
52 340-375 Disease denotes acute respiratory distress syndrome MESH:D012128
53 386-391 Disease denotes death MESH:D003643
54 604-613 Disease denotes infection MESH:D007239
55 871-880 Disease denotes infection MESH:D007239
56 924-932 Disease denotes COVID-19 MESH:C000657245
57 2067-2083 Disease denotes thrombocytopenia MESH:D013921
58 2085-2097 Disease denotes hypertension MESH:D006973
59 2111-2123 Disease denotes inflammation MESH:D007249
60 2167-2175 Disease denotes COVID-19 MESH:C000657245
61 2249-2257 Disease denotes COVID-19 MESH:C000657245
79 2474-2484 Species denotes SARS-CoV-2 Tax:2697049
80 2627-2633 Species denotes people Tax:9606
81 2890-2898 Species denotes patients Tax:9606
82 4072-4082 Species denotes SARS-CoV-2 Tax:2697049
83 2424-2448 Disease denotes coronavirus disease 2019 MESH:C000657245
84 2450-2458 Disease denotes COVID-19 MESH:C000657245
85 2564-2572 Disease denotes COVID-19 MESH:C000657245
86 2618-2626 Disease denotes infected MESH:D007239
87 2677-2697 Disease denotes respiratory symptoms MESH:D012818
88 2714-2723 Disease denotes pneumonia MESH:D011014
89 2914-2933 Disease denotes respiratory illness MESH:D012140
90 2978-2987 Disease denotes mortality MESH:D003643
91 3278-3286 Disease denotes COVID-19 MESH:C000657245
92 3492-3512 Disease denotes SARS-CoV-2 infection MESH:C000657245
93 3675-3683 Disease denotes COVID-19 MESH:C000657245
94 3812-3820 Disease denotes COVID-19 MESH:C000657245
95 3910-3918 Disease denotes COVID-19 MESH:C000657245
110 4942-4948 Gene denotes BCL11A Gene:53335
111 4280-4288 Species denotes patients Tax:9606
112 4555-4560 Species denotes human Tax:9606
113 5564-5569 Species denotes human Tax:9606
114 4116-4136 Disease denotes SARS-CoV-2 infection MESH:C000657245
115 4147-4155 Disease denotes COVID-19 MESH:C000657245
116 4271-4279 Disease denotes COVID-19 MESH:C000657245
117 4343-4348 Disease denotes COVID MESH:C000657245
118 4379-4387 Disease denotes COVID-19 MESH:C000657245
119 4531-4551 Disease denotes SARS-CoV-2 infection MESH:C000657245
120 5182-5193 Disease denotes thalassemia MESH:D013789
121 5540-5560 Disease denotes SARS-CoV-2 infection MESH:C000657245
122 5646-5655 Disease denotes infection MESH:D007239
123 5687-5695 Disease denotes COVID-19 MESH:C000657245
137 5863-5894 Gene denotes Angiotensin converting enzyme 2 Gene:59272
138 5896-5900 Gene denotes ACE2 Gene:59272
139 6002-6033 Gene denotes transmembrane Serine Protease 2 Gene:7113
140 6035-6042 Gene denotes TMPRSS2 Gene:7113
141 6147-6151 Gene denotes ACE2 Gene:59272
142 6232-6239 Gene denotes TMPRSS2 Gene:7113
143 6424-6428 Gene denotes ACE2 Gene:59272
144 6480-6484 Gene denotes ACE2 Gene:59272
145 6746-6750 Gene denotes ACE2 Gene:59272
146 6724-6729 Species denotes human Tax:9606
147 5789-5809 Disease denotes SARS-CoV-2 infection MESH:C000657245
148 6305-6320 Disease denotes prostate cancer MESH:D011471
149 6325-6334 Disease denotes mortality MESH:D003643
153 6867-6871 Gene denotes ACE2 Gene:59272
154 6876-6883 Gene denotes TMPRSS2 Gene:7113
155 7596-7611 Disease denotes CoV-2 infection MESH:C000657245
157 8088-8100 Species denotes participants Tax:9606
159 8470-8497 Disease denotes MultiEthnic Disease Version MESH:D003141
162 10586-10593 Species denotes CVD III Tax:551523
163 10879-10890 Species denotes participant Tax:9606
166 11778-11782 Gene denotes ACE2 Gene:59272
167 11824-11831 Gene denotes TMPRSS2 Gene:7113
180 13205-13209 Gene denotes ACE2 Gene:59272
181 13383-13387 Gene denotes ACE2 Gene:59272
182 13554-13559 Gene denotes CHIT1 Gene:1118
183 13562-13569 Gene denotes TMPRSS2 Gene:7113
184 13732-13739 Gene denotes TMPRSS2 Gene:7113
185 13727-13729 Gene denotes TR Gene:2149
186 13160-13162 Disease denotes AF MESH:D001281
187 13191-13193 Disease denotes SE
188 13211-13221 Mutation denotes rs17264937 rs17264937
189 13389-13398 Mutation denotes rs5980163 rs5980163
190 13571-13582 Mutation denotes rs150965978 rs150965978
191 13741-13751 Mutation denotes rs28401567 rs28401567
194 13089-13093 Gene denotes ACE2 Gene:59272
195 13098-13105 Gene denotes TMPRSS2 Gene:7113
205 13988-13992 Gene denotes ACE2 Gene:59272
206 13997-14004 Gene denotes TMPRSS2 Gene:7113
207 14291-14296 Gene denotes CHIT1 Gene:1118
208 14315-14320 Gene denotes CHIT1 Gene:1118
209 14330-14332 Gene denotes TR Gene:2149
210 14271-14274 Chemical denotes TGL
211 14276-14289 Chemical denotes triglycerides MESH:D014280
212 14196-14198 Disease denotes AF MESH:D001281
213 14234-14236 Disease denotes SE
215 15968-15974 Chemical denotes Dprime
230 16289-16293 Gene denotes ACE2 Gene:59272
231 16298-16305 Gene denotes TMPRSS2 Gene:7113
232 16592-16596 Gene denotes ACE2 Gene:59272
233 16771-16778 Gene denotes TMPRSS2 Gene:7113
234 16812-16817 Gene denotes CHIT1 Gene:1118
235 16972-16976 Gene denotes ACE2 Gene:59272
236 17571-17576 Gene denotes CHIT1 Gene:1118
237 16613-16626 Chemical denotes triglycerides MESH:D014280
238 16955-16968 Chemical denotes triglycerides MESH:D014280
239 16940-16949 Mutation denotes rs5980163 rs5980163
240 16687-16697 Mutation denotes rs17264937 rs17264937
241 16819-16830 Mutation denotes rs150965978 rs150965978
242 16866-16876 Mutation denotes rs28401567 rs28401567
243 16628-16637 Mutation denotes rs5980163 rs5980163
246 17693-17697 Gene denotes ACE2 Gene:59272
247 17764-17768 Gene denotes ACE2 Gene:59272
253 18694-18701 Gene denotes TMPRSS2 Gene:7113
254 18768-18775 Gene denotes TMPRSS2 Gene:7113
255 19483-19491 Disease denotes melanoma MESH:D008545
256 19518-19527 Disease denotes mortality MESH:D003643
257 19533-19548 Disease denotes prostate cancer MESH:D011471
263 19984-19988 Gene denotes ACE2 Gene:59272
264 20526-20530 Gene denotes ACE2 Gene:59272
265 20050-20057 Chemical denotes steroid MESH:D013256
266 20119-20123 Mutation denotes M01A p.M01A
267 20207-20216 Mutation denotes rs4646190 rs4646190
277 20845-20849 Gene denotes ACE2 Gene:59272
278 21023-21027 Gene denotes ACE2 Gene:59272
279 21200-21207 Gene denotes TMPRSS2 Gene:7113
280 21381-21388 Gene denotes TMPRSS2 Gene:7113
281 20790-20792 Disease denotes AF MESH:D001281
282 20851-20860 Mutation denotes rs4646190 rs4646190
283 21209-21217 Mutation denotes rs457274 rs457274
284 21374-21378 Mutation denotes D07A p.D07A
285 21390-21399 Mutation denotes rs9975623 rs9975623
288 20711-20715 Gene denotes ACE2 Gene:59272
289 20720-20727 Gene denotes TMPRSS2 Gene:7113
296 21661-21665 Gene denotes ACE2 Gene:59272
297 21670-21677 Gene denotes TMPRSS2 Gene:7113
298 21932-21940 Chemical denotes steroids MESH:D013256
299 21822-21824 Disease denotes AF MESH:D001281
300 21876-21880 Mutation denotes M01A p.M01A
301 22040-22044 Mutation denotes D07A p.D07A
307 22141-22150 Chemical denotes ibuprofen MESH:D007052
308 22099-22103 Disease denotes pain MESH:D010146
309 22105-22110 Disease denotes fever MESH:D005334
310 22115-22127 Disease denotes inflammation MESH:D007249
311 22172-22181 Mutation denotes rs4646190 rs4646190
315 22391-22403 Disease denotes hypertension MESH:D006973
316 22444-22456 Disease denotes hypertensive MESH:D006973
317 23014-23026 Disease denotes hypertension MESH:D006973
320 23689-23696 Gene denotes TMPRSS2 Gene:7113
321 23840-23844 Mutation denotes D07A p.D07A
326 24852-24856 Mutation denotes M01A p.M01A
327 24470-24474 Mutation denotes D07A p.D07A
328 24573-24577 Mutation denotes M01A p.M01A
329 24448-24452 Mutation denotes M01A p.M01A
337 25220-25224 Gene denotes ACE2 Gene:59272
338 25289-25293 Gene denotes ACE2 Gene:59272
339 25332-25339 Gene denotes TMPRSS2 Gene:7113
340 25204-25214 Species denotes SARS-CoV-2 Tax:2697049
341 25504-25514 Species denotes SARS-CoV-2 Tax:2697049
342 25600-25605 Species denotes human Tax:9606
343 25534-25542 Disease denotes COVID-19 MESH:C000657245
348 26240-26253 Chemical denotes triglycerides MESH:D014280
349 26293-26316 Disease denotes cardiovascular diseases MESH:D002318
350 26356-26364 Disease denotes COVID-19 MESH:C000657245
351 26574-26582 Disease denotes COVID-19 MESH:C000657245
361 26916-26920 Gene denotes ACE2 Gene:59272
362 27164-27171 Gene denotes TMPRSS2 Gene:7113
363 27440-27444 Gene denotes ACE2 Gene:59272
364 28178-28182 Gene denotes ACE2 Gene:59272
365 27322-27330 Disease denotes COVID-19 MESH:C000657245
366 27873-27885 Disease denotes hypertension MESH:D006973
367 27898-27910 Disease denotes inflammation MESH:D007249
368 27063-27072 Mutation denotes rs4646190 rs4646190
369 27179-27189 Mutation denotes rs75833467 rs75833467
377 28771-28774 Gene denotes ACE Gene:1636
378 28946-28949 Gene denotes ACE Gene:1636
379 28747-28755 Species denotes patients Tax:9606
380 28793-28801 Disease denotes coughing MESH:D003371
381 28968-28976 Disease denotes coughing MESH:D003371
382 29146-29158 Disease denotes hypertension MESH:D006973
383 29364-29373 Mutation denotes rs4646190 rs4646190
391 30301-30311 Species denotes SARS-CoV-2 Tax:2697049
392 29844-29856 Disease denotes hypertension MESH:D006973
393 29869-29881 Disease denotes inflammation MESH:D007249
394 29914-29922 Disease denotes COVID-19 MESH:C000657245
395 30099-30107 Disease denotes COVID-19 MESH:C000657245
396 30330-30338 Disease denotes COVID-19 MESH:C000657245
397 30406-30414 Disease denotes COVID-19 MESH:C000657245
400 31420-31428 Species denotes patients Tax:9606
401 31366-31374 Disease denotes COVID-19 MESH:C000657245
405 31604-31608 Gene denotes ACE2 Gene:59272
406 31613-31620 Gene denotes TMPRSS2 Gene:7113
407 31670-31675 Species denotes human Tax:9606
413 31999-32009 Species denotes SARS-CoV-2 Tax:2697049
414 32218-32226 Species denotes patients Tax:9606
415 32088-32096 Disease denotes COVID-19 MESH:C000657245
416 32127-32135 Disease denotes COVID-19 MESH:C000657245
417 32232-32240 Disease denotes COVID-19 MESH:C000657245
421 32691-32696 Species denotes human Tax:9606
422 32697-32709 Species denotes participants Tax:9606
423 32952-32964 Species denotes participants Tax:9606
427 33070-33072 Disease denotes PD MESH:D010300
428 33106-33108 Disease denotes MG MESH:D000080343
429 33317-33319 Disease denotes PD MESH:D010300
431 33451-33453 Disease denotes PD MESH:D010300
433 34178-34180 Disease denotes PD MESH:D010300
435 35098-35101 Gene denotes SPI Gene:1113

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 83-91 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T2 94-103 Disease denotes Infection http://purl.obolibrary.org/obo/MONDO_0005550
T3 148-172 Disease denotes Coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T4 174-182 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 281-284 Disease denotes flu http://purl.obolibrary.org/obo/MONDO_0005812
T6 329-338 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T7 340-375 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T8 346-375 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T9 567-575 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T10 604-613 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T11 871-880 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T12 924-932 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T13 2067-2083 Disease denotes thrombocytopenia http://purl.obolibrary.org/obo/MONDO_0002049
T14 2085-2097 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T15 2111-2123 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T16 2167-2175 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T17 2249-2257 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T18 2424-2448 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T19 2450-2458 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T20 2474-2482 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T21 2564-2572 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T22 2714-2723 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T23 3278-3286 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T24 3492-3500 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T25 3503-3512 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T26 3675-3683 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T27 3812-3820 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T28 3910-3918 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T29 4072-4080 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T30 4116-4124 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T31 4127-4136 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T32 4147-4155 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T33 4271-4279 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T34 4379-4387 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T35 4531-4539 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T36 4542-4551 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T37 5177-5193 Disease denotes beta-thalassemia http://purl.obolibrary.org/obo/MONDO_0013517
T38 5182-5193 Disease denotes thalassemia http://purl.obolibrary.org/obo/MONDO_0000984
T39 5198-5218 Disease denotes sickle cell diseases http://purl.obolibrary.org/obo/MONDO_0011382
T40 5540-5548 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T41 5551-5560 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T42 5646-5655 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T43 5687-5695 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T44 5789-5797 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T45 5800-5809 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T46 6305-6320 Disease denotes prostate cancer http://purl.obolibrary.org/obo/MONDO_0008315
T47 6314-6320 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T48 7591-7599 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T49 7602-7611 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T50 13191-13193 Disease denotes SE http://purl.obolibrary.org/obo/MONDO_0002125
T51 14234-14236 Disease denotes SE http://purl.obolibrary.org/obo/MONDO_0002125
T52 19483-19491 Disease denotes melanoma http://purl.obolibrary.org/obo/MONDO_0005105
T53 19533-19548 Disease denotes prostate cancer http://purl.obolibrary.org/obo/MONDO_0008315
T54 19542-19548 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T55 22115-22127 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T56 22391-22403 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T57 22542-22545 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T58 22922-22925 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T59 23014-23026 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T60 23187-23190 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T61 25204-25212 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T62 25504-25512 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T63 25534-25542 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T64 26293-26316 Disease denotes cardiovascular diseases http://purl.obolibrary.org/obo/MONDO_0004995
T65 26356-26364 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T66 26574-26582 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T67 27322-27330 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T68 27873-27885 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T69 27898-27910 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T70 29146-29158 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T71 29844-29856 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T72 29869-29881 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T73 29914-29922 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T74 30099-30107 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T75 30301-30309 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T76 30330-30338 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T77 30406-30414 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T78 31366-31374 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T79 31999-32007 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T80 32088-32096 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T81 32127-32135 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T82 32232-32240 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 65-70 http://purl.obolibrary.org/obo/OGG_0000000002 denotes Genes
T2 108-113 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes Human
T3 190-191 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T4 454-459 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T5 454-459 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T6 464-471 http://purl.obolibrary.org/obo/UBERON_0003100 denotes females
T7 578-583 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T8 629-634 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T9 635-645 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes: the
T10 646-651 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T11 704-708 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T12 805-810 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T13 885-890 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T14 976-977 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T15 1050-1055 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T16 1065-1070 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T17 1548-1553 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T18 1633-1637 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T19 1803-1810 http://purl.obolibrary.org/obo/UBERON_0003100 denotes females
T20 2040-2041 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T21 2485-2490 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T22 2491-2494 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T23 2510-2511 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T24 2531-2532 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T25 2573-2576 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T26 2577-2578 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T27 3304-3309 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T28 3304-3309 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T29 3314-3321 http://purl.obolibrary.org/obo/UBERON_0003100 denotes females
T30 4513-4518 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T31 4555-4560 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T32 4729-4730 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T33 4949-4953 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T34 5205-5209 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T35 5520-5525 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T36 5564-5569 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T37 5939-5944 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T38 5959-5963 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T39 6134-6138 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T40 6485-6489 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T41 6522-6523 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T42 6724-6729 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T43 6863-6865 http://purl.obolibrary.org/obo/CLO_0007074 denotes Kb
T44 6863-6865 http://purl.obolibrary.org/obo/CLO_0051988 denotes Kb
T45 6904-6905 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T46 7147-7153 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T47 7175-7176 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T48 7297-7301 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T49 7297-7301 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T50 7311-7317 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T51 7311-7317 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T52 7311-7317 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T53 7386-7387 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T54 7506-7511 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T55 7506-7511 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T56 7516-7523 http://purl.obolibrary.org/obo/UBERON_0003100 denotes females
T57 7703-7704 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T58 7772-7773 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T59 8172-8173 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T60 8376-8377 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T61 8760-8761 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T62 8855-8860 http://purl.obolibrary.org/obo/CLO_0008285 denotes p < 1
T63 8855-8860 http://purl.obolibrary.org/obo/CLO_0008286 denotes p < 1
T64 9348-9349 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T65 9501-9502 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T66 9834-9835 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T67 10023-10029 http://purl.obolibrary.org/obo/UBERON_0003100 denotes female
T68 10299-10302 http://purl.obolibrary.org/obo/CL_0000613 denotes BAP
T69 10336-10338 http://purl.obolibrary.org/obo/CLO_0008480 denotes PQ
T70 10342-10344 http://purl.obolibrary.org/obo/CLO_0007815 denotes MO
T71 10471-10473 http://purl.obolibrary.org/obo/CLO_0050050 denotes S1
T72 10494-10500 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T73 10648-10654 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T74 10802-10806 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T75 10992-10995 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T76 11087-11091 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T77 11392-11394 http://purl.obolibrary.org/obo/CLO_0008922 denotes S2
T78 11392-11394 http://purl.obolibrary.org/obo/CLO_0050052 denotes S2
T79 11623-11627 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T80 11665-11670 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T81 11665-11670 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T82 11699-11705 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T83 11774-11776 http://purl.obolibrary.org/obo/CLO_0007074 denotes Kb
T84 11774-11776 http://purl.obolibrary.org/obo/CLO_0051988 denotes Kb
T85 12161-12162 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T86 12199-12201 http://purl.obolibrary.org/obo/CLO_0050050 denotes S1
T87 12557-12562 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T88 12557-12562 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T89 12567-12574 http://purl.obolibrary.org/obo/UBERON_0003100 denotes females
T90 13120-13124 http://purl.obolibrary.org/obo/OGG_0000000002 denotes Gene
T91 13286-13291 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Males
T92 13286-13291 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Males
T93 13328-13335 http://purl.obolibrary.org/obo/UBERON_0003100 denotes Females
T94 13464-13469 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Males
T95 13464-13469 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Males
T96 13511-13518 http://purl.obolibrary.org/obo/UBERON_0003100 denotes Females
T97 13599-13600 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T98 13647-13652 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Males
T99 13647-13652 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Males
T100 13686-13693 http://purl.obolibrary.org/obo/UBERON_0003100 denotes Females
T101 13818-13823 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Males
T102 13818-13823 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Males
T103 13860-13867 http://purl.obolibrary.org/obo/UBERON_0003100 denotes Females
T104 14298-14304 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T105 14367-14373 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T106 14417-14418 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T107 14617-14624 http://purl.obolibrary.org/obo/UBERON_0000982 denotes jointly
T108 14617-14624 http://purl.obolibrary.org/obo/UBERON_0004905 denotes jointly
T109 15279-15280 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T110 15556-15557 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T111 15631-15632 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T112 15658-15659 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T113 16170-16171 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T114 16370-16372 http://purl.obolibrary.org/obo/CLO_0050050 denotes S1
T115 16795-16801 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T116 16984-16985 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T117 17014-17019 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T118 17014-17019 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T119 17024-17031 http://purl.obolibrary.org/obo/UBERON_0003100 denotes females
T120 17043-17047 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T121 17080-17086 http://purl.obolibrary.org/obo/SO_0000418 denotes signal
T122 17109-17114 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T123 17109-17114 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T124 17204-17210 http://purl.obolibrary.org/obo/SO_0000418 denotes signal
T125 17241-17246 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T126 17241-17246 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T127 17250-17257 http://purl.obolibrary.org/obo/UBERON_0003100 denotes females
T128 17259-17264 http://purl.obolibrary.org/obo/CLO_0008285 denotes p > 1
T129 17259-17264 http://purl.obolibrary.org/obo/CLO_0008286 denotes p > 1
T130 17577-17583 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T131 17642-17646 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T132 17827-17828 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T133 17829-17830 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T134 17886-17887 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T135 18109-18110 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T136 18289-18290 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T137 18331-18332 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T138 18338-18345 http://purl.obolibrary.org/obo/CLO_0002697 denotes (D), an
T139 18506-18511 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T140 18834-18835 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T141 18836-18837 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T142 18893-18894 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T143 19115-19116 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T144 19295-19296 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T145 19337-19338 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T146 19344-19351 http://purl.obolibrary.org/obo/CLO_0002697 denotes (D), an
T147 19585-19590 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T148 19766-19773 http://purl.obolibrary.org/obo/CLO_0009985 denotes focused
T149 19945-19947 http://purl.obolibrary.org/obo/CLO_0008922 denotes S2
T150 19945-19947 http://purl.obolibrary.org/obo/CLO_0050052 denotes S2
T151 20750-20754 http://purl.obolibrary.org/obo/OGG_0000000002 denotes Gene
T152 20874-20875 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T153 20927-20932 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Males
T154 20927-20932 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Males
T155 20939-20942 http://purl.obolibrary.org/obo/CLO_0001360 denotes 412
T156 20973-20980 http://purl.obolibrary.org/obo/UBERON_0003100 denotes Females
T157 20987-20990 http://purl.obolibrary.org/obo/CLO_0050053 denotes 862
T158 21052-21053 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T159 21104-21109 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Males
T160 21104-21109 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Males
T161 21144-21151 http://purl.obolibrary.org/obo/UBERON_0003100 denotes Females
T162 21158-21161 http://purl.obolibrary.org/obo/CLO_0053001 denotes 114
T163 21284-21289 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Males
T164 21284-21289 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Males
T165 21325-21332 http://purl.obolibrary.org/obo/UBERON_0003100 denotes Females
T166 21414-21415 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T167 21466-21471 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Males
T168 21466-21471 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Males
T169 21513-21520 http://purl.obolibrary.org/obo/UBERON_0003100 denotes Females
T170 22198-22203 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T171 22198-22203 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T172 22229-22236 http://purl.obolibrary.org/obo/UBERON_0003100 denotes females
T173 22358-22359 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T174 22487-22488 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T175 22571-22574 http://purl.obolibrary.org/obo/CLO_0051145 denotes Ram
T176 23116-23121 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T177 23116-23121 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T178 23126-23133 http://purl.obolibrary.org/obo/UBERON_0003100 denotes females
T179 23164-23170 http://purl.obolibrary.org/obo/SO_0000418 denotes signal
T180 23238-23245 http://purl.obolibrary.org/obo/UBERON_0003100 denotes females
T181 23355-23362 http://purl.obolibrary.org/obo/UBERON_0003100 denotes females
T182 23412-23417 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T183 23412-23417 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T184 24631-24636 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T185 24631-24636 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T186 24700-24707 http://purl.obolibrary.org/obo/UBERON_0003100 denotes females
T187 24726-24727 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T188 24810-24816 http://purl.obolibrary.org/obo/SO_0000418 denotes signal
T189 25122-25123 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T190 25255-25260 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T191 25303-25307 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T192 25408-25413 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T193 25438-25442 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T194 25600-25605 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T195 25738-25739 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T196 25878-25883 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T197 25946-25950 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T198 25946-25950 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T199 25960-25966 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T200 25960-25966 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T201 25960-25966 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T202 26216-26223 http://purl.obolibrary.org/obo/SO_0000418 denotes signals
T203 26528-26529 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T204 26650-26660 http://purl.obolibrary.org/obo/CL_0000000 denotes cell types
T205 26874-26875 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T206 27090-27091 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T207 27520-27525 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T208 27520-27525 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T209 27717-27722 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T210 27717-27722 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T211 27919-27920 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T212 27946-27949 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T213 28490-28492 http://purl.obolibrary.org/obo/CLO_0050050 denotes S1
T214 28565-28566 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T215 28618-28619 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T216 29194-29197 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T217 29395-29396 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T218 30425-30426 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T219 30484-30488 http://purl.obolibrary.org/obo/UBERON_0002535 denotes Gill
T220 31005-31011 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T221 31075-31082 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T222 31621-31626 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T223 31638-31639 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T224 31670-31675 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T225 31893-31898 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T226 31945-31958 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T227 32691-32696 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T228 33113-33115 http://purl.obolibrary.org/obo/CLO_0007874 denotes MS
T229 33471-33472 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T230 33490-33496 http://purl.obolibrary.org/obo/CLO_0002910 denotes EL (1)
T231 33516-33522 http://purl.obolibrary.org/obo/CLO_0009133 denotes SS (1)
T232 33544-33550 http://purl.obolibrary.org/obo/CLO_0007875 denotes MS (1)
T233 33544-33550 http://purl.obolibrary.org/obo/CLO_0050048 denotes MS (1)
T234 33544-33550 http://purl.obolibrary.org/obo/CLO_0052410 denotes MS (1)
T235 34052-34053 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T236 34111-34112 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T237 34236-34240 http://purl.obolibrary.org/obo/CLO_0009609 denotes wish
T238 34631-34634 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T239 34652-34653 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T240 35036-35048 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T241 35151-35154 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T242 35613-35618 http://purl.obolibrary.org/obo/UBERON_0003103 denotes Organ
T243 35672-35677 http://purl.obolibrary.org/obo/UBERON_0000948 denotes Heart
T244 35672-35677 http://purl.obolibrary.org/obo/UBERON_0007100 denotes Heart
T245 35672-35677 http://purl.obolibrary.org/obo/UBERON_0015228 denotes Heart
T246 35672-35677 http://www.ebi.ac.uk/efo/EFO_0000815 denotes Heart
T247 35700-35704 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T248 35705-35707 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T249 35709-35711 http://purl.obolibrary.org/obo/CLO_0007874 denotes MS
T250 35947-35952 http://purl.obolibrary.org/obo/UBERON_0000948 denotes Heart
T251 35947-35952 http://purl.obolibrary.org/obo/UBERON_0007100 denotes Heart
T252 35947-35952 http://purl.obolibrary.org/obo/UBERON_0015228 denotes Heart
T253 35947-35952 http://www.ebi.ac.uk/efo/EFO_0000815 denotes Heart
T254 35975-35979 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T255 35980-35982 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T256 36373-36375 http://purl.obolibrary.org/obo/CLO_0050050 denotes S1
T257 36407-36408 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T258 36517-36518 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T259 36638-36639 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T260 36713-36714 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T261 36838-36843 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T262 37035-37036 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 661-672 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T2 727-733 Chemical denotes serine http://purl.obolibrary.org/obo/CHEBI_17822
T3 757-764 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T4 1499-1509 Chemical denotes nucleotide http://purl.obolibrary.org/obo/CHEBI_36976
T5 1674-1688 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T8 1674-1685 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T9 1686-1688 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T10 1855-1862 Chemical denotes steroid http://purl.obolibrary.org/obo/CHEBI_35341
T11 4022-4026 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T12 5021-5031 Chemical denotes hemoglobin http://purl.obolibrary.org/obo/CHEBI_35143
T13 5177-5181 Chemical denotes beta http://purl.obolibrary.org/obo/CHEBI_10545
T14 5456-5461 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T15 5863-5874 Chemical denotes Angiotensin http://purl.obolibrary.org/obo/CHEBI_2719
T16 5984-5992 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T17 6016-6022 Chemical denotes Serine http://purl.obolibrary.org/obo/CHEBI_17115|http://purl.obolibrary.org/obo/CHEBI_17822
T19 6110-6118 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T20 7084-7088 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T21 7129-7136 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T22 7647-7653 Chemical denotes Cohort http://purl.obolibrary.org/obo/CHEBI_34935
T23 10278-10281 Chemical denotes MAP http://purl.obolibrary.org/obo/CHEBI_6716
T24 10299-10302 Chemical denotes BAP http://purl.obolibrary.org/obo/CHEBI_29022
T25 10336-10338 Chemical denotes PQ http://purl.obolibrary.org/obo/CHEBI_74757
T26 10476-10483 Chemical denotes Protein http://purl.obolibrary.org/obo/CHEBI_16541
T27 10531-10539 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T28 10655-10665 Chemical denotes citrulline http://purl.obolibrary.org/obo/CHEBI_18211
T29 10846-10850 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T30 11227-11231 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T31 11356-11360 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T32 11392-11394 Chemical denotes S2 http://purl.obolibrary.org/obo/CHEBI_29387
T33 11904-11914 Chemical denotes nucleotide http://purl.obolibrary.org/obo/CHEBI_36976
T34 13154-13157 Chemical denotes Alt http://purl.obolibrary.org/obo/CHEBI_37708
T35 13185-13189 Chemical denotes beta http://purl.obolibrary.org/obo/CHEBI_10545
T36 13191-13193 Chemical denotes SE http://purl.obolibrary.org/obo/CHEBI_74813
T37 13727-13729 Chemical denotes TR http://purl.obolibrary.org/obo/CHEBI_74825
T38 14171-14174 Chemical denotes Alt http://purl.obolibrary.org/obo/CHEBI_37708
T39 14234-14236 Chemical denotes SE http://purl.obolibrary.org/obo/CHEBI_74813
T40 14276-14289 Chemical denotes triglycerides http://purl.obolibrary.org/obo/CHEBI_17855
T41 14321-14328 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T42 14330-14332 Chemical denotes TR http://purl.obolibrary.org/obo/CHEBI_74825
T43 14374-14382 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T44 15803-15807 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T45 16613-16626 Chemical denotes triglycerides http://purl.obolibrary.org/obo/CHEBI_17855
T46 16955-16968 Chemical denotes triglycerides http://purl.obolibrary.org/obo/CHEBI_17855
T47 18118-18125 Chemical denotes diamond http://purl.obolibrary.org/obo/CHEBI_33417
T48 19124-19131 Chemical denotes diamond http://purl.obolibrary.org/obo/CHEBI_33417
T49 19945-19947 Chemical denotes S2 http://purl.obolibrary.org/obo/CHEBI_29387
T50 20017-20022 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T51 20026-20031 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T52 20050-20057 Chemical denotes steroid http://purl.obolibrary.org/obo/CHEBI_35341
T53 20104-20110 Chemical denotes NSAIDs http://purl.obolibrary.org/obo/CHEBI_35475
T54 20252-20257 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T55 20272-20286 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T58 20272-20283 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T59 20284-20286 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T60 20338-20360 Chemical denotes antihypertensive drugs http://purl.obolibrary.org/obo/CHEBI_35674
T61 20355-20360 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T62 20784-20787 Chemical denotes Alt http://purl.obolibrary.org/obo/CHEBI_37708
T63 21621-21625 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T64 21797-21800 Chemical denotes Alt http://purl.obolibrary.org/obo/CHEBI_37708
T65 21932-21940 Chemical denotes steroids http://purl.obolibrary.org/obo/CHEBI_35341
T66 21948-21962 Chemical denotes Angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719
T67 21960-21962 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T68 22070-22076 Chemical denotes NSAIDs http://purl.obolibrary.org/obo/CHEBI_35475
T69 22141-22150 Chemical denotes ibuprofen http://purl.obolibrary.org/obo/CHEBI_132922|http://purl.obolibrary.org/obo/CHEBI_5855
T71 22331-22336 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T72 22340-22345 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T73 22457-22462 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T74 22512-22528 Chemical denotes antihypertensive http://purl.obolibrary.org/obo/CHEBI_35674
T75 23725-23730 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T76 23734-23739 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T77 23817-23832 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T78 24308-24312 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T79 24550-24561 Chemical denotes glucosamine http://purl.obolibrary.org/obo/CHEBI_5417
T80 24652-24663 Chemical denotes candesartan http://purl.obolibrary.org/obo/CHEBI_3347
T81 24721-24723 Chemical denotes S3 http://purl.obolibrary.org/obo/CHEBI_29388
T82 24875-24877 Chemical denotes S4 http://purl.obolibrary.org/obo/CHEBI_29401
T83 26240-26253 Chemical denotes triglycerides http://purl.obolibrary.org/obo/CHEBI_17855
T84 27034-27053 Chemical denotes antirheumatic drugs http://purl.obolibrary.org/obo/CHEBI_35842
T85 27048-27053 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T86 27055-27061 Chemical denotes NSAIDs http://purl.obolibrary.org/obo/CHEBI_35475
T87 27302-27308 Chemical denotes NSAIDs http://purl.obolibrary.org/obo/CHEBI_35475
T88 27628-27633 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T89 27928-27932 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T90 28775-28784 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T91 28861-28865 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T92 28950-28959 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T93 29419-29425 Chemical denotes NSAIDs http://purl.obolibrary.org/obo/CHEBI_35475
T94 29683-29689 Chemical denotes NSAIDs http://purl.obolibrary.org/obo/CHEBI_35475
T95 29813-29818 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T96 30381-30387 Chemical denotes NSAIDs http://purl.obolibrary.org/obo/CHEBI_35475
T97 30744-30748 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T98 32432-32443 Chemical denotes application http://purl.obolibrary.org/obo/CHEBI_33232
T99 33016-33018 Chemical denotes EL http://purl.obolibrary.org/obo/CHEBI_73506
T100 33023-33025 Chemical denotes AG http://purl.obolibrary.org/obo/CHEBI_27569|http://purl.obolibrary.org/obo/CHEBI_40618|http://purl.obolibrary.org/obo/CHEBI_73757
T103 33058-33060 Chemical denotes EL http://purl.obolibrary.org/obo/CHEBI_73506
T104 33062-33064 Chemical denotes AG http://purl.obolibrary.org/obo/CHEBI_27569|http://purl.obolibrary.org/obo/CHEBI_40618|http://purl.obolibrary.org/obo/CHEBI_73757
T107 33066-33068 Chemical denotes PL http://purl.obolibrary.org/obo/CHEBI_74791|http://purl.obolibrary.org/obo/CHEBI_81588
T109 33070-33072 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T110 33082-33084 Chemical denotes SS http://purl.obolibrary.org/obo/CHEBI_73653
T111 33106-33108 Chemical denotes MG http://purl.obolibrary.org/obo/CHEBI_73611
T112 33113-33115 Chemical denotes MS http://purl.obolibrary.org/obo/CHEBI_73613
T113 33176-33182 Chemical denotes Cohort http://purl.obolibrary.org/obo/CHEBI_34935
T114 33190-33192 Chemical denotes LF http://purl.obolibrary.org/obo/CHEBI_73585
T115 33238-33240 Chemical denotes EL http://purl.obolibrary.org/obo/CHEBI_73506
T116 33242-33244 Chemical denotes AG http://purl.obolibrary.org/obo/CHEBI_27569|http://purl.obolibrary.org/obo/CHEBI_40618|http://purl.obolibrary.org/obo/CHEBI_73757
T119 33250-33252 Chemical denotes SS http://purl.obolibrary.org/obo/CHEBI_73653
T120 33305-33307 Chemical denotes PL http://purl.obolibrary.org/obo/CHEBI_74791|http://purl.obolibrary.org/obo/CHEBI_81588
T122 33309-33311 Chemical denotes LF http://purl.obolibrary.org/obo/CHEBI_73585
T123 33317-33319 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T124 33390-33396 Chemical denotes Cohort http://purl.obolibrary.org/obo/CHEBI_34935
T125 33451-33453 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T126 33459-33461 Chemical denotes LF http://purl.obolibrary.org/obo/CHEBI_73585
T127 33490-33492 Chemical denotes EL http://purl.obolibrary.org/obo/CHEBI_73506
T128 33516-33518 Chemical denotes SS http://purl.obolibrary.org/obo/CHEBI_73653
T129 33544-33546 Chemical denotes MS http://purl.obolibrary.org/obo/CHEBI_73613
T130 34178-34180 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T131 34286-34292 Chemical denotes Cohort http://purl.obolibrary.org/obo/CHEBI_34935
T132 34557-34559 Chemical denotes NL http://purl.obolibrary.org/obo/CHEBI_141422
T133 35488-35494 Chemical denotes Cohort http://purl.obolibrary.org/obo/CHEBI_34935
T134 35709-35711 Chemical denotes MS http://purl.obolibrary.org/obo/CHEBI_73613
T135 36838-36843 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 329-338 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T2 346-366 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T3 853-880 Phenotype denotes predisposition to infection http://purl.obolibrary.org/obo/HP_0002719
T4 2067-2083 Phenotype denotes thrombocytopenia http://purl.obolibrary.org/obo/HP_0001873
T5 2085-2097 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T6 2714-2723 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T7 2914-2933 Phenotype denotes respiratory illness http://purl.obolibrary.org/obo/HP_0002086
T8 6305-6320 Phenotype denotes prostate cancer http://purl.obolibrary.org/obo/HP_0012125
T9 19483-19491 Phenotype denotes melanoma http://purl.obolibrary.org/obo/HP_0002861
T10 19533-19548 Phenotype denotes prostate cancer http://purl.obolibrary.org/obo/HP_0012125
T11 22099-22103 Phenotype denotes pain http://purl.obolibrary.org/obo/HP_0012531
T12 22105-22110 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T13 22391-22403 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T14 23014-23026 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T15 26293-26316 Phenotype denotes cardiovascular diseases http://purl.obolibrary.org/obo/HP_0001626
T16 27873-27885 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T17 28793-28801 Phenotype denotes coughing http://purl.obolibrary.org/obo/HP_0012735
T18 28853-28874 Phenotype denotes adverse drug reaction http://purl.obolibrary.org/obo/HP_0020172
T19 28876-28879 Phenotype denotes ADR http://purl.obolibrary.org/obo/HP_0020172
T20 28968-28976 Phenotype denotes coughing http://purl.obolibrary.org/obo/HP_0012735
T21 29146-29158 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T22 29844-29856 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 2111-2123 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T2 3578-3593 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T3 7854-7863 http://purl.obolibrary.org/obo/GO_0007610 denotes behaviors
T4 18566-18579 http://purl.obolibrary.org/obo/GO_0006351 denotes transcription
T5 19645-19658 http://purl.obolibrary.org/obo/GO_0006351 denotes transcription
T6 20531-20541 http://purl.obolibrary.org/obo/GO_0006351 denotes transcript
T7 22115-22127 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T8 26560-26570 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T9 27898-27910 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T10 29869-29881 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T11 34573-34580 http://purl.obolibrary.org/obo/GO_0051235 denotes storage

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-137 Sentence denotes Lack of Association Between Genetic Variants at ACE2 and TMPRSS2 Genes Involved in SARS-CoV-2 Infection and Human Quantitative Phenotypes
T2 139-147 Sentence denotes Abstract
T3 148-392 Sentence denotes Coronavirus disease 2019 (COVID-19) shows a wide variation in expression and severity of symptoms, from very mild or no symptoms, to flu-like symptoms, and in more severe cases, to pneumonia, acute respiratory distress syndrome, and even death.
T4 393-472 Sentence denotes Large differences in outcome have also been observed between males and females.
T5 473-562 Sentence denotes The causes for this variability are likely to be multifactorial, and to include genetics.
T6 563-773 Sentence denotes The SARS-CoV-2 virus responsible for the infection depends on two human genes: the human receptor angiotensin converting enzyme 2 (ACE2) for cell invasion, and the serine protease TMPRSS2 for S protein priming.
T7 774-901 Sentence denotes Genetic variation in these two genes may thus modulate an individual's genetic predisposition to infection and virus clearance.
T8 902-1108 Sentence denotes While genetic data on COVID-19 patients is being gathered, we carried out a phenome-wide association scan (PheWAS) to investigate the role of these genes in other human phenotypes in the general population.
T9 1109-1370 Sentence denotes We examined 178 quantitative phenotypes including cytokines and cardio-metabolic biomarkers, as well as usage of 58 medications in 36,339 volunteers from the Lifelines population cohort, in relation to 1,273 genetic variants located in or near ACE2 and TMPRSS2.
T10 1371-1478 Sentence denotes While none reached our threshold for significance, we observed several interesting suggestive associations.
T11 1479-1611 Sentence denotes For example, single nucleotide polymorphisms (SNPs) near the TMPRSS2 genes were associated with thrombocytes count (p = 1.8 × 10−5).
T12 1612-1925 Sentence denotes SNPs within the ACE2 gene were associated with (1) the use of angiotensin II receptor blockers (ARBs) combination therapies (p = 5.7 × 10−4), an association that is significantly stronger in females (pdiff = 0.01), and (2) with the use of non-steroid anti-inflammatory and antirheumatic products (p = 5.5 × 10−4).
T13 1926-2182 Sentence denotes While these associations need to be confirmed in larger sample sizes, they suggest that these variants could play a role in diseases such as thrombocytopenia, hypertension, and chronic inflammation that are often observed in the more severe COVID-19 cases.
T14 2183-2324 Sentence denotes Further investigation of these genetic variants in the context of COVID-19 is thus promising for better understanding of disease variability.
T15 2325-2382 Sentence denotes Full results are available at https://covid19research.nl.
T16 2384-2396 Sentence denotes Introduction
T17 2397-2563 Sentence denotes The recent outbreak of the coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has quickly become a pandemic and poses a great threat to public health.
T18 2564-2804 Sentence denotes COVID-19 has a wide range of clinical manifestations: infected people can be asymptomatic, symptomatic with mild respiratory symptoms, or have severe pneumonia (Chen et al., 2020; Huang et al., 2020; Wu and McGoogan, 2020; Xu et al., 2020).
T19 2805-3038 Sentence denotes Estimates based on reported cases from February 2020 in China indicated that ~20% of patients develop severe respiratory illness requiring hospitalization, and that overall mortality estimates are around 2.3% (Wu and McGoogan, 2020).
T20 3039-3150 Sentence denotes These estimates are not fixed and are becoming more precise as more cases are reported, screened, and analyzed.
T21 3151-3464 Sentence denotes Interestingly, there is high variability in these estimates when comparing countries and continents, as well as differences in COVID-19 severity between males and females and between different age groups (Chen et al., 2020; Wu and McGoogan, 2020; Zhou et al., 2020) [WHO Situation Report 70, from March 30, 2020].
T22 3465-3767 Sentence denotes Differences in response to SARS-CoV-2 infection between individuals and countries may be explained by diminished immune response in the elderly, comorbidities, or smoking habits (Guan et al., 2020), but severe COVID-19 cases have also been observed in young individuals, seemingly without risk factors.
T23 3768-3848 Sentence denotes This indicates that most factors explaining COVID-19 severity are still unknown.
T24 3849-4092 Sentence denotes It is therefore critical to understand the mechanisms behind COVID-19 severity in order to provide appropriate prevention measures and adequate triage strategies, guide the drug discovery process, and ultimately combat the SARS-CoV-2 pandemic.
T25 4093-4233 Sentence denotes The large variation in SARS-CoV-2 infection rates and COVID-19 severity could potentially be explained by genetic differences between hosts.
T26 4234-4649 Sentence denotes While large-scale genetic studies of COVID-19 patients are being assembled, such as those coordinated by the COVID host genetics consortium (The COVID-19 Host Genetics Initiative, 2020; https://www.covid19hg.org/), it is worthwhile to evaluate the effects of genetic variants in genes involved in SARS-CoV-2 infection on human phenotypes, including quantitative traits, taking advantage of already existing cohorts.
T27 4650-4880 Sentence denotes In fact, while quantitative phenotypes are not always directly associated with a disease, knowledge on the genetic variants that modulate these traits can improve our understanding of disease onset and the variability in symptoms.
T28 4881-5259 Sentence denotes In one example of how this can work, genetic variants in the BCL11A gene were associated by genome-wide association studies (GWAS) to fetal hemoglobin (HbF) production in the general population (Menzel et al., 2007), and these genetic variants were subsequently found to modulate the severity of beta-thalassemia and sickle cell diseases (Lettre et al., 2008; Uda et al., 2008).
T29 5260-5462 Sentence denotes This observation explained why certain individuals were naturally predisposed to mild symptoms of these diseases, while others had very severe clinical outcomes and benefitted from HbF increasing drugs.
T30 5463-5752 Sentence denotes Therefore, understanding the role of genetic variants at genes essential for SARS-CoV-2 infection in human quantitative phenotypes is important to explain the observed variability in infection susceptibility and severity of COVID-19 and this understanding may suggest potential treatments.
T31 5753-5862 Sentence denotes Some factors that are necessary for SARS-CoV-2 infection are known (Hoffmann et al., 2020; Yan et al., 2020).
T32 5863-6171 Sentence denotes Angiotensin converting enzyme 2 (ACE2) is necessary for the invasion of the virus into the host cell through viral spike proteins, and the transmembrane Serine Protease 2 (TMPRSS2) is necessary for the correct maturation of these same viral spike proteins that enter the cell through ACE2 (Yan et al., 2020).
T33 6172-6429 Sentence denotes According to the GWAS Catalog1, genetic variants in or near TMPRSS2, located on chromosome 21, are associated with susceptibility of prostate cancer and mortality rate in the population, while no associations have been reported for variants in or near ACE2.
T34 6430-6695 Sentence denotes This can be partly explained by the fact that the ACE2 gene is located on the X chromosome, a part of the genome that is often not analyzed by large scale genome wide association studies (GWAS) due to differences in analysis workflow with the autosomal chromosomes.
T35 6696-6784 Sentence denotes Potential associations with human phenotypes near ACE2 could have therefore been missed.
T36 6785-7003 Sentence denotes Here we investigated the association of genetic variants within or near (±100 Kb) ACE2 and TMPRSS2 transcripts through a phenome-wide association scan (PheWAS) in 36,339 volunteers from the Lifelines population cohort.
T37 7004-7204 Sentence denotes We analyzed 72 quantitative phenotypes and the medication usage of 58 different drug categories in the entire cohort, and 92 protein levels in plasma, and 14 cytokines in a subset of ~600 individuals.
T38 7205-7373 Sentence denotes The quantitative phenotypes selected are anthropometric traits and measurable parameters of lung, hearth, kidney, hematological, immune, and cardio-metabolic functions.
T39 7374-7612 Sentence denotes Finally, in a sex-stratified anaysis we evaluated whether these variants were sex-specific or differed in their association between males and females to explore potential differences between sexes that could modulate SARS-CoV-2 infection.
T40 7614-7635 Sentence denotes Materials and Methods
T41 7637-7653 Sentence denotes Lifelines Cohort
T42 7654-7926 Sentence denotes The Lifelines cohort (Scholtens et al., 2015) is a multi-disciplinary prospective population-based cohort study, with a unique three generation design, that is examining the health and health-related behaviors of 167,729 individuals living in the North of the Netherlands.
T43 7927-8083 Sentence denotes It was approved by the medical ethics committee of the University Medical Center Groningen and conducted in accordance with Helsinki Declaration Guidelines.
T44 8084-8153 Sentence denotes All participants signed an informed consent form prior to enrollment.
T45 8154-8358 Sentence denotes Lifelines employs a broad range of investigative procedures to assess the impact of biomedical, socio-demographic, behavioral, physical, and psychological factors on multi-morbidity, and complex genetics.
T46 8360-8375 Sentence denotes Genotyping Data
T47 8376-8644 Sentence denotes A subset of 38,030 volunteers were genotyped using the Infinium Global Screening Array® (GSA) MultiEthnic Disease Version, according to manufacturer's instructions, at the Rotterdam genotyping center and the Department of Genetics, University Medical Center Groningen.
T48 8645-8997 Sentence denotes We performed standard quality controls on both samples and markers, including removal of samples and variants with a low genotyping call rate (<99%), variants showing deviation from Hardy-Weinberg equilibrium (p < 1 × 10−6) or excess of Mendelian errors in families (>1% of the parent-offspring pairs), and samples with very high or low heterozygosity.
T49 8998-9347 Sentence denotes We further checked and removed samples that did not show consistent information between reported sex and genotypes on the X chromosome, between reported familial information and observed identity-by-descent sharing with family members, and between genotypes available from this and previous studies (Francioli et al., 2015; Tigchelaar et al., 2015).
T50 9348-9478 Sentence denotes A detailed description of the process can be found at the following link: https://covid19research.nl (van der Velde et al., 2019).
T51 9479-9602 Sentence denotes After quality checks, a total of 36,339 samples and 571,420 autosomal and X-chromosome markers were available for analysis.
T52 9603-9937 Sentence denotes The genotyping dataset was then imputed using the Haplotype Reference Consortium (HRC) panel v1.1 at the Sanger imputation server1 (Consortium, 2015), and variants with an imputation quality score higher than 0.4 for variants with a minor allele frequency (MAF) > 0.01 and higher than 0.8 for rare variants (MAF < 0.01) were retained.
T53 9938-10104 Sentence denotes 58.40% (21,241) of the 36,339 individuals whose genotype passed quality control were female, and the average age at phenotype collection was 39.9 years (±16.3 years).
T54 10106-10116 Sentence denotes Phenotypes
T55 10117-10204 Sentence denotes Quantitative phenotypes were measured as previously described (Scholtens et al., 2015).
T56 10205-10475 Sentence denotes We removed illegal zero or negative values for the “QRS,” “QT,” “HALB,” “MAP,” “MOP,” “EOP,” “BAP,” “U24HVOL,” “ALT,” “HR,” “EO,” “PQ,” “MO,” and “BA” phenotypes, and removed−999 values from the electrocardiogram phenotypes “P_AXIS,” “T_AXIS,” and “QRS_AXIS” (Table S1).
T57 10476-10808 Sentence denotes Protein levels in plasma for 92 cardiovascular-related proteins were determined using Olink Proseek Multiplex CVD III panel (OLINK, Uppsala, Sweden), and concentrations of plasma citrulline and cytokines were measured by ProcartaPlex™ multiplex immunoassay (eBioscience, USA) as described previously (Zhernakova et al., 2016, 2018).
T58 10809-10948 Sentence denotes Medication use was recorded based on drug packaging brought in by the participant's on their first visit to the Lifelines inclusion center.
T59 10949-11093 Sentence denotes Registration of medication use in this way has been shown to be fairly to highly concordant with health record information (Sediq et al., 2018).
T60 11094-11268 Sentence denotes After conversion to anatomical therapeutic chemical classification (ATC) codes, the first four letters (level 3) were used to define drug categories for association analyses.
T61 11269-11396 Sentence denotes ATC codes with less than 100 observations were not considered for analysis, leaving 58 drug categories for analysis (Table S2).
T62 11398-11418 Sentence denotes Statistical Analyses
T63 11419-11629 Sentence denotes We analyzed quantitative phenotypes using linear-mixed models implemented in SAIGEgds v1.0.0 so as to correct for familial relationships and cryptic population structure (Zheng et al., 2017; Zhou et al., 2018).
T64 11630-11695 Sentence denotes For the X chromosome, genotypes in males were considered diploid.
T65 11696-11882 Sentence denotes We tested the additive effect of 1,273 genetic variants within and near (±100 Kb) ACE2 (chrX:15,579,156-15,620,271, GRCh37) and TMPRSS2 (chr21:42,836,478-42,903,043, GRCh37) transcripts.
T66 11883-12065 Sentence denotes These are all single-nucleotide polymorphisms (SNPs) with minor allele frequency (MAF) > 0.005 that were genotyped or imputed and that passed our quality controls as described above.
T67 12066-12203 Sentence denotes Analysis through SAIGEgds was carried out for 72 quantitative phenotypes available for all, or a subset of the 36,339 samples (Table S1).
T68 12204-12363 Sentence denotes Drug categories were analyzed as binary traits (1 = if medication currently in use, 0 otherwise) and restricted only to 1,240 genetic variants with MAF > 0.01.
T69 12364-12417 Sentence denotes In both analyses age and sex were used as covariates.
T70 12418-12506 Sentence denotes Inverse-normal transformation was applied to all quantitative traits prior to model fit.
T71 12507-12716 Sentence denotes We searched for sex-specific effects by analyzing males and females separately (sex-stratified analyses), using only age as covariate and the same transformations as used for the analysis on the entire cohort.
T72 12717-12887 Sentence denotes We also used the sex-stratified anaysis results to investigated differential genetic effects between sexes at suggestive associations identified in the combined analysis.
T73 12888-13030 Sentence denotes This approach is typically used in small to moderate studies as an alternative to an analysis with an interaction term (Winkler et al., 2015).
T74 13031-13111 Sentence denotes Table 1 Most-significant associations with phenotypes at ACE2 and TMPRSS2 loci.
T75 13112-13199 Sentence denotes Trait Gene rs.id Chr:position Ref/Alt AF.Alt Analysis N beta (SE) p
T76 13200-13285 Sentence denotes EO ACE2 rs17264937 X:15647332 T/C 0.312 All 35,494 0.416 (0.11) 1.49 × 10−4
T77 13286-13327 Sentence denotes Males only 14,751 0.357 (0.146) 0.0146
T78 13328-13376 Sentence denotes Females only 20,743 0.531 (0.159) 8.17 × 10−4
T79 13377-13463 Sentence denotes TGL ACE2 rs5980163 X:15521666 C/G 0.016 All 36,112 0.071 (0.019) 1.63 × 10−4
T80 13464-13510 Sentence denotes Males only 15,004 0.108 (0.031) 4.12 × 10−4
T81 13511-13553 Sentence denotes Females only 21,108 0.014 (0.021) 0.488
T82 13554-13646 Sentence denotes CHIT1 TMPRSS2 rs150965978 21:42942652 C/A 0.063 All 526 −0.630 (0.131) 2.13 × 10−6
T83 13647-13685 Sentence denotes Males only 241 −0.502 (0.209) 0.017
T84 13686-13726 Sentence denotes Females only 285 −0.555 (0.175) 0.002
T85 13727-13817 Sentence denotes TR TMPRSS2 rs28401567 21:42951813 C/T 0.166 All 36,049 −2.50 (0.583) 1.77 × 10−5
T86 13818-13859 Sentence denotes Males only 14,975 −1.82 (0.788) 0.0210
T87 13860-13908 Sentence denotes Females only 21,074 −2.74 (0.775) 4.04 × 10−4
T88 13909-14010 Sentence denotes The table reports summary statistics for the two most-associated phenotypes at ACE2 and TMPRSS2 loci.
T89 14011-14051 Sentence denotes Positions refer to genome build GRCh 37.
T90 14052-14147 Sentence denotes Beta indicates the effect for each copy of the alternative allele, in standard deviation units.
T91 14148-14347 Sentence denotes Ref, reference allele; Alt, alternative allele; AF.Alt, alternative allele frequency; SE, Standard Error; EO, Eosinophils; TGL, triglycerides; CHIT1, plasma levels of CHIT1 protein; TR, thrombocytes.
T92 14348-14520 Sentence denotes The 92 circulating plasma proteins and 14 cytokines were measured in a small subset of unrelated individuals and thus did not require correction for familial relationships.
T93 14521-14563 Sentence denotes These were analyzed using PLINK v2.00a3LM.
T94 14564-14714 Sentence denotes We performed the association mapping with both sexes jointly, or separately as described above, and using inverse-normal transformation on the traits.
T95 14715-14977 Sentence denotes We analyzed each variant and trait combination with or without the inclusion of age and sex covariates, as some genetic variants were too highly correlated due to the small sample size, and thus an estimate with covariates included in the model was not possible.
T96 14978-15088 Sentence denotes To evaluate the statistical power of our study we used the package GeneticsDesign in R (Weilang et al., 2019).
T97 15089-15383 Sentence denotes For quantitative variable analyses, we used the function GeneticPower.Quantitative.Numeric() and calculated the minimum detectable additive effect (variance explained) with 80% power and at a significance threshold of 5 × 10−8, for an increasing number of samples up to 36,339 (our study size).
T98 15384-15707 Sentence denotes For binary variables analysis, we used the function GPC.default() and calculated the minimum detectable additive effect size (genotype relative risk) with 80% power and at a significance threshold of 5 × 10−8, for an increasing number of cases in a cohort of 36,339 and for a risk allele frequency varying from 0.05 to 0.5.
T99 15708-15832 Sentence denotes We set the number of cases up to 4,000 to reflect the maximum number of users for the analyzed drug categories in our study.
T100 15833-16000 Sentence denotes We also assumed that the causal variant was included in our genotyping data set, therefore we constrained full linkage disequilibrium (Dprime = 1) with the tag marker.
T101 16001-16129 Sentence denotes Since disease prevalence (pD) could also impact power, we calculated the minimum detectable effect for pD varying from 1 to 20%.
T102 16131-16138 Sentence denotes Results
T103 16140-16163 Sentence denotes Quantitative Phenotypes
T104 16164-16374 Sentence denotes Using a linear-mixed model, we analyzed 1,273 common and low frequency (MAF > 0.005) genetic variants in and near (+/−100Kb) ACE2 and TMPRSS2 transcripts for association with 178 quantitative traits (Table S1).
T105 16375-16519 Sentence denotes None were found to be significant at the standard genome-wide level (p = 5 × 10−8) or at the Benjamin-Hochberg false discovery rate (FDR < 0.1).
T106 16520-16736 Sentence denotes The most significant associations found with quantitative traits at the ACE2 locus were with triglycerides (rs5980163, p = 1.6 × 10−4) and with the eosinophil counts (rs17264937, p = 1.5 × 10−4) (Table 1) (Figure 1).
T107 16737-16915 Sentence denotes The strongest associations at the TMPRSS2 locus were with plasma levels of CHIT1 (rs150965978, p = 2.1 × 10−6) and thrombocytes (rs28401567, p = 1.7 × 10−5) (Table 1) (Figure 2).
T108 16916-17183 Sentence denotes Only the association at rs5980163 with triglycerides at ACE2 showed a differential effect between males and females (Cochran Q-test pdiff = 0.01), with most of the signal being attributable to males, although the association remains only suggestive (p = 4.12 × 10−4).
T109 17184-17325 Sentence denotes We did not find any signal that was restricted to either males or females (p > 1 × 10−6 for all associations in the sex-stratified analyses).
T110 17326-17512 Sentence denotes The SNP-trait associations reported in Table 1 were not replicated in the UK Biobank, based on summary statistics from an analysis that included at least 343,992 samples1 (all p > 0.05).
T111 17513-17648 Sentence denotes No replication was observed also for the association with CHIT1 plasma levels using results from the INTERVAL study (Sun et al., 2018).
T112 17649-17704 Sentence denotes Figure 1 Regional associations plot at the ACE2 locus.
T113 17705-17850 Sentence denotes Graphical representation of the association results at the ACE2 locus for the SNP-trait associations reported in Table 1 (A,B) and Table 2 (C,D).
T114 17851-18058 Sentence denotes In each panel, each dot represents a genetic variant, and shown is the association strength (expressed as negative log10 P-values, Y-axis) vs. the genomic position (on the hg19/GRCh37 genomic build, X-axis).
T115 18059-18288 Sentence denotes The strongest associated variant is depicted with a purple diamond, while other variants are color-coded to reflect their linkage disequilibrium with it (taken from pairwise r2 values calculated from the 1,000 Genomes Europeans).
T116 18289-18334 Sentence denotes A legend for color-coding is provided in (A).
T117 18335-18580 Sentence denotes In (D), an additional box shows the location of associations reported in the GWAS catalog (no associations were reported at this locus) and below this box the location of genes is shown with specification of exons and direction of transcription.
T118 18581-18649 Sentence denotes This figure was drawn using LocusZoom web tool (Pruim et al., 2010).
T119 18650-18708 Sentence denotes Figure 2 Regional associations plot at the TMPRSS2 locus.
T120 18709-18857 Sentence denotes Graphical representation of the association results at the TMPRSS2 locus for the SNP-trait associations reported in Table 1 (A,B) and Table 2 (C,D).
T121 18858-19064 Sentence denotes In each panel, each dot represents a genetic variant and shown is the association strength (expressed as negative log10 P-values, Y-axis) vs. the genomic position (on the hg19/GRCh37 genomic build, X-axis).
T122 19065-19294 Sentence denotes The strongest associated variant is depicted with a purple diamond, while other variants are color-coded to reflect their linkage disequilibrium with it (taken from pairwise r2 values calculated from the 1,000 Genomes Europeans).
T123 19295-19340 Sentence denotes A legend for color-coding is provided in (A).
T124 19341-19727 Sentence denotes In (D), an additional box shows the location of associations reported in the GWAS catalog (associations here reported from left to right are: melanoma, age-related diseases and mortality, and prostate cancer) and below this box the location of genes is shown with specification of exons and direction of transcription This figure was drawn using LocusZoom web tool (Pruim et al., 2010).
T125 19729-19743 Sentence denotes Medication Use
T126 19744-19808 Sentence denotes For this analysis, we focused on 1,240 variants with MAF > 0.01.
T127 19809-19949 Sentence denotes As with the quantitative phenotypes, none of the genetic variants showed genome-wide significant association with medication use (Table S2).
T128 19950-20474 Sentence denotes The strongest associations at the ACE2 locus were observed for the group of drugs that contains non-steroid anti-inflammatory and antirheumatic products (NSAIDs) (ATC = M01A) [odds ratio (OR) = 1.34, 95% C.I. = 1.14–1.58, p = 5.5 × 10−4 for the G allele of rs4646190] (Table 2) (Figure 1), and for the group that contains angiotensin II receptor blockers (ARBs) in combination with other antihypertensive drugs (ATC = C09D) (OR = 1.35, 95% C.I. = 1.14–1.62 p = 5.7 × 10−4 for the T allele of rs4646156) (Table 2) (Figure 1).
T129 20475-20647 Sentence denotes These SNPs are both located in intron eight of the ACE2 transcript and only 525 bp apart, but they are not in linkage disequilibrium (r2 = 0.05 in 1,000 Genomes Europeans).
T130 20648-20733 Sentence denotes Table 2 Most-significant associations with medications use at ACE2 and TMPRSS2 loci.
T131 20734-20837 Sentence denotes Drug ATC code Gene rs.id Chr:position Ref/Alt AF.Alt Analysis N users OR (95%C.I.) p
T132 20838-20926 Sentence denotes M01A ACE2 rs4646190 X:15597568 A/G 0.045 All 1,274 1.34 (1.14–1.58) 5.5 × 10−4
T133 20927-20972 Sentence denotes Males only 412 1.54 (1.22–1.97) 3.7 × 10−4
T134 20973-21015 Sentence denotes Females only 862 1.16 (0.92–1.46) 0.213
T135 21016-21103 Sentence denotes C09D ACE2 rs4646156 X:15597043 A/T 0.646 All 202 1.36 (1.14–1.62) 5.71 × 10−4
T136 21104-21143 Sentence denotes Males only 88 1.14 (0.92–1.42) 0.231
T137 21144-21192 Sentence denotes Females only 114 1.78 (1.35–2.34) 4.69 × 10−5
T138 21193-21283 Sentence denotes J02A TMPRSS2 rs457274 21:42792485 C/G 0.406 All 523 1.33 (1.16–1.51) 3.36 × 10−4
T139 21284-21324 Sentence denotes Males only 234 1.23 (1.01–1.50) 0.041
T140 21325-21373 Sentence denotes Females only 289 1.41 (1.25–1.60) 1.46 × 10−4
T141 21374-21465 Sentence denotes D07A TMPRSS2 rs9975623 21:42920296 A/G 0.304 All 897 1.23 (1.07–1.36) 1.04 × 10−4
T142 21466-21512 Sentence denotes Males only 348 1.29 (1.09–1.51) 2.52 × 10−3
T143 21513-21555 Sentence denotes Females only 549 1.19 (1.04–1.35) 0.011
T144 21556-21683 Sentence denotes The table reports summary statistics for the two most-associated drug categories (given in ATC codes) at ACE2 and TMPRSS2 loci.
T145 21684-21724 Sentence denotes Positions refer to genome build GRCh 37.
T146 21725-21773 Sentence denotes The Odds Ratio refers to the alternative allele.
T147 21774-22069 Sentence denotes Ref, reference allele; Alt, alternative allele; AF.alt, alternative allele frequency; OR, Odds ratio; M01A, Anti-inflammatory and antirheumatic products, non-steroids; C09D, Angiotensin II receptor blockers (ARBs), combinations; J02A, Antimycotics for systemic use; D07A, Corticosteroids, plain.
T148 22070-22151 Sentence denotes NSAIDs are used for treating pain, fever and inflammation, and include ibuprofen.
T149 22152-22319 Sentence denotes The significance of rs4646190 was stronger in males (p = 3.7 × 10−4) than in females (p = 0.08), but the effect sizes were not statistically different (pdiff = 0.054).
T150 22320-22404 Sentence denotes The second group of drugs encodes for a combined therapy used to treat hypertension.
T151 22405-22595 Sentence denotes Combination therapy of ARBs with other hypertensive drugs is usually initiated as a second option when the antihypertensive effect of an ARB alone is not sufficient (Ram, 2004; Flack, 2007).
T152 22596-22788 Sentence denotes Our results indicate that individuals carrying at least one T allele at the rs4646156 polymorphism were more likely to take this combined therapy compared to individuals with the other allele.
T153 22789-22894 Sentence denotes The effect of this SNP was also not significant when considering only ARBs intake (ATC = C09C, p = 0.66).
T154 22895-23085 Sentence denotes Thus, the association with ARB combination therapies could indicate that individuals in whom it is difficult to manage hypertension may be genetically predisposed to this state by rs4646156.
T155 23086-23433 Sentence denotes Interestingly, when analyzing males and females separately, we found that the signal of rs4646156 on ARB combination therapy was mostly attributable to females, even when accounting for differences in number of users (OR = 1.78, 95% C.I. = 1.35–2.34, p = 4.7 × 10−5 in females vs. OR = 1.14, 95% C.I. = 0.92–1.42, p = 0.23 in males, pdiff = 0.01).
T156 23434-23593 Sentence denotes We reiterate that none of these associations (in the combined and in the sex-specific analyses) meet either the genome-wide or FDR thresholds for significance.
T157 23594-23654 Sentence denotes To confirm these findings larger sample sizes are necessary.
T158 23655-23884 Sentence denotes The strongest associations at the TMPRSS2 locus were observed for the group of drugs containing antimycotics prescriptions (ATC = J02A) (p = 3.65 × 10−5) and for corticosteroids (ATC = D07A) (p = 1.0 × 10−4) (Table 2) (Figure 2).
T159 23885-23994 Sentence denotes No significant difference in effect size between sexes was observed for these two associations (pdiff > 0.2).
T160 23995-24115 Sentence denotes These SNPs were independent from each other and from the top associations with quantitative traits described in Table 1.
T161 24116-24324 Sentence denotes We attempted to validate our findings on medication use using again the UK Biobank public GWAS summary statistics1, although their data refers to the use of individual medications rather than drug categories.
T162 24325-24725 Sentence denotes When considering the medications most commonly used (>1,000 users in the UK Biobank cohort) in the categories of interest (M01A, C09D, J02A, and D07A), we found nominal association with the same direction of effects only for glucosamine use (ATC = M01A, p = 0.002 in the combined analysis and p = 0.008 in males only) and with candesartan cilexetin (ATC = C09D, p = 0.008 in females only) (Table S3).
T163 24726-24879 Sentence denotes A similar detailed analysis in our cohort was underpowered to detect an association signal for single medications of C09D and M01A categories (Table S4).
T164 24880-24988 Sentence denotes This lack of replication could be attributable to differences in medication usage reporting between studies.
T165 24989-25153 Sentence denotes While both are based on self-reported information, in the Lifelines study records are confirmed by medication packaging collected by a nurse during the recruitment.
T166 25155-25165 Sentence denotes Discussion
T167 25166-25375 Sentence denotes Recent studies have demonstrated that SARS-CoV-2 uses ACE2 as the key receptor to invade cells (Yan et al., 2020) and that ACE2-mediated cell invasion is enhanced by TMPRSS2 expression (Hoffmann et al., 2020).
T168 25376-25552 Sentence denotes Genetic variations in these two genes that interfere with the gene function may thus be involved in the observed variability of SARS-CoV-2 susceptibility and COVID-19 severity.
T169 25553-25724 Sentence denotes The association of these genetic variants with human phenotypes in the general population may suggest potential treatments and help to better identify at-risk individuals.
T170 25725-26022 Sentence denotes Here we used a cohort of 36,339 individuals from the Lifelines general population cohort to investigate the impact of variants near and within these two genes on 178 quantitative traits including measurable parameters of lung, hearth, kidney, hematological, immune, and cardio-metabolic functions.
T171 26023-26189 Sentence denotes We found no significant evidence that common and low frequency variants in these loci were associated with the measured quantitative traits in the general population.
T172 26190-26495 Sentence denotes We did observe suggestive signals for phenotypes (triglycerides and thrombocytes) that are involved in cardiovascular diseases, which are considered risk factors for COVID-19 diseases (Wu and McGoogan, 2020), but none of the genetic variants reached statistical significance despite our large sample size.
T173 26496-26717 Sentence denotes Nevertheless, we cannot exclude a role of these variants in the regulation of COVID-19 severity through other relevant phenotypes such as specific immune cell types or cytokine levels that were not measured in our cohort.
T174 26718-26861 Sentence denotes To evaluate the effect of genetic variation in clinically relevant phenotypes, we investigated the association of genetics with medication use.
T175 26862-27074 Sentence denotes We observed a marginal association of variants within ACE2 with use of ARBs combination therapy (ATC = C09D, rs4646156) and with use of non-steroidal anti-inflammatory and antirheumatic drugs (NSAIDs, rs4646190).
T176 27075-27207 Sentence denotes Interestingly, a marginal association with ARBs (C09C category) was also observed at the TMPRSS2 locus (rs75833467, p = 3.5 × 10−4).
T177 27208-27456 Sentence denotes These results are intriguing considering the current debate about whether the use of ARBs and NSAIDs could worsen COVID-19 severity (Kuster et al., 2020; Little, 2020; Russell et al., 2020), and their potential effect on increasing ACE2 expression.
T178 27457-27676 Sentence denotes No significant associations were found for these variants with blood pressure measurements or inflammatory markers in our cohort (p < 0.05), not even when the use of such drugs were added as covariates (data not shown).
T179 27677-27785 Sentence denotes Association with diastolic and systolic blood pressure was also not observed in the large UK Biobank cohort.
T180 27786-27942 Sentence denotes Thus, these variants are likely to be associated only with clinical conditions such as hypertension and chronic inflammation or with a better drug response.
T181 27943-28230 Sentence denotes It has to be noted that our sample size allowed sufficient statistical power to detect genetic variants with small effects (down to 0.001 of variance explained), and thus we are confident in claiming lack of association at TMPRS22 and ACE2 loci with the quantitative phenotypes assessed.
T182 28231-28494 Sentence denotes For analyses on medication usage we were instead sufficiently powered to find small effects (genotype relative risk ~1.1) only for very common SNPs (frequency >0.3), but we are underpowered for smaller effects and, in general, at less common variants (Figure S1).
T183 28495-28654 Sentence denotes Therefore, our suggestive results for medication usage could indicate a real effect for which we were underpowered to find a genome-wide significance evidence.
T184 28655-28707 Sentence denotes Further exploration of these associations is needed.
T185 28708-28802 Sentence denotes ARBs are the preferred alternative for patients who experience ACE-inhibitor induced coughing.
T186 28803-28996 Sentence denotes However, as rs4646156 is not associated with this adverse drug reaction (ADR), our results are likely independent of the switch to ARBs due to ACE-inhibitor induced coughing (Mas et al., 2011).
T187 28997-29159 Sentence denotes Interestingly, the association of this SNP with ARBs was specific to ARBs combination therapy, thus pointing to individuals with difficult-to-manage hypertension.
T188 29160-29239 Sentence denotes The major allele (T) of rs4646156 has different frequencies across populations:
T189 29240-29333 Sentence denotes 0.653 in Europeans, 0.997 in East Asians and 0.797 South Asians, according to 1,000 Genomes1.
T190 29334-29489 Sentence denotes Likewise, the G allele at the rs4646190 SNP, associated with a higher probability of NSAIDs use, shows substantial different frequencies among populations.
T191 29490-29541 Sentence denotes It is mostly absent in Asians but not in Europeans:
T192 29542-29633 Sentence denotes 0.03 in Europeans, 0 in East Asians and 0.003 in South Asians, according to 1,000 Genomes1.
T193 29634-29937 Sentence denotes The suggestive genetics associations we find for NSAIDs and ARBs combination therapy indicate that, depending on their genotype, certain individuals are predisposed to take these drugs, and thus to suffer from hypertension and chronic inflammation, diseases often described among COVID-19 comorbidities.
T194 29938-30145 Sentence denotes This, together with the observed different allele frequencies across continents and the sex-related differential effects could explain the observed variation in COVID-19 severity between countries and sexes.
T195 30146-30424 Sentence denotes Unfortunately, we could only speculate around this hypothesis as this study is not suited to prove that these genetic associations are directly related to SARS-CoV-2 susceptibility or COVID-19 severity, nor we can determine if ARBs or NSAIDs improve or worsen COVID-19 severity.
T196 30425-30544 Sentence denotes A role of ARBs in worsing severity seems however unlikely (Gill et al., 2020; Mancia et al., 2020; Mehra et al., 2020).
T197 30545-30599 Sentence denotes We acknowledge the following limitations in our study.
T198 30600-30848 Sentence denotes First, only age and sex were used as covariates in our analyses, which may not be sufficient to correct for confounders for all traits, such as drug usage or diseases, although the effect of these confounders should be mitigated by our sample size.
T199 30849-31105 Sentence denotes Secondly, our analyses on medication use are underpowered given the limited number of individuals in the general population who use the medications that we tested, and thus none of the associations found here met the multiple-testing adjusted significance.
T200 31106-31265 Sentence denotes Third, our results for medication use did not include low frequency and none of the analysis include rare variants (MAF < 0.005) which could still be relevant.
T201 31266-31473 Sentence denotes Fourth, while we can speculate about potential connections of our results with current knowledge of COVID-19, longitudinal and well-characterized data on patients is needed to further explore our hypothesis.
T202 31474-31735 Sentence denotes In conclusion we carried out an extensive screening of potential genetic associations at common and low frequency variants in the ACE2 and TMPRSS2 genes, and found a lack of substantial effect in human quantitative phenotype variation in the general population.
T203 31736-31850 Sentence denotes Genetic analyses in more phenotypes are needed to evaluate their functional role in other physiological processes.
T204 31851-32315 Sentence denotes Finally, since genetic variation in other genes, for example those involved in regulating the immune system, could also be important in determining SARS-CoV-2 susceptibility and disease severity, large scale genetic initiatives like the COVID-19 host genetics consortium (The COVID-19 Host Genetics Initiative, 2020; https://www.covid19hg.com/) that directly involve patients with COVID-19 and deeply characterization of genomes and phenotypes are urgently needed.
T205 32317-32344 Sentence denotes Data Availability Statement
T206 32345-32461 Sentence denotes The data analyzed in this study was obtained from the Lifelines biobank, under project application number OV18_0463.
T207 32462-32566 Sentence denotes Requests to access this dataset should be directed to Lifelines Research Office (research@lifelines.nl).
T208 32567-32650 Sentence denotes Full summary statistics of the results are available at https://covid19research.nl.
T209 32652-32668 Sentence denotes Ethics Statement
T210 32669-32877 Sentence denotes The studies involving human participants were reviewed and approved by the medical ethics committee of the University Medical Center Groningen and conducted in accordance with Helsinki Declaration Guidelines.
T211 32878-32993 Sentence denotes Written informed consent to participate in this study was provided by the participants' legal guardian/next of kin.
T212 32995-33015 Sentence denotes Author Contributions
T213 33016-33057 Sentence denotes EL and AG performed statistical analyses.
T214 33058-33105 Sentence denotes EL, AG, PL, PD, AZ, and SS interpreted results.
T215 33106-33165 Sentence denotes MG and MS provided computing infrastructure and web portal.
T216 33166-33237 Sentence denotes Lifelines Cohort Study, LF, CW, JF, and AZ provided access to the data.
T217 33238-33332 Sentence denotes EL, AG, and SS wrote the manuscript draft with critical input from PL, LF, CW, PD, JF, and AZ.
T218 33333-33378 Sentence denotes All authors read and approved the manuscript.
T219 33380-33425 Sentence denotes Lifelines Cohort Study—Group Authors Genetics
T220 33426-33576 Sentence denotes Raul Aguirre-Gamboa (1), PD (1), LF (1), Jan A Kuivenhoven (2), EL (1), Ilja M Nolte (3), SS (1), Harold Snieder (3), MS (1), Judith M Vonk (3), CW(1)
T221 33577-33679 Sentence denotes (1) Department of Genetics, University of Groningen, University Medical Center Groningen, Netherlands.
T222 33680-33784 Sentence denotes (2) Department of Pediatrics, University of Groningen, University Medical Center Groningen, Netherlands.
T223 33785-33890 Sentence denotes (3)Department of Epidemiology, University of Groningen, University Medical Center Groningen, Netherlands.
T224 33892-33912 Sentence denotes Conflict of Interest
T225 33913-34085 Sentence denotes The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
T226 34086-34222 Sentence denotes The reviewer JK declared a shared affiliation with no collaboration with one of the authors PD to the handling editor at time of review.
T227 34224-34395 Sentence denotes The authors wish to acknowledge the services of the Lifelines Cohort Study, the contributing research centers delivering data to Lifelines, and all the study participants.
T228 34396-34412 Sentence denotes We also thank K.
T229 34413-34614 Sentence denotes McIntyre for editorial assistance, and the UMCG Genomics Coordination center, the UG Center for Information Technology and their sponsors BBMRI-NL & TarGet for storage and computational infrastructure.
T230 34615-34714 Sentence denotes This manuscript has been released as a pre-print at https://www.medrxiv.org/ (Lopera et al., 2020).
T231 34715-34983 Sentence denotes 11000 Genomes study: https://www.internationalgenome.org/; Sanger imputation server: https://imputation.sanger.ac.uk; GWAS catalogue: https://www.ebi.ac.uk/gwas/home (accessed on April 6, 2020); UK biobank all phenotype associations: http://www.nealelab.is/uk-biobank.
T232 34984-34992 Sentence denotes Funding.
T233 34993-35117 Sentence denotes This work was supported by the Netherlands Organization for Scientific Research (NWO): NWO Spinoza Prize SPI 92-266 (to CW).
T234 35118-35417 Sentence denotes The Lifelines Biobank initiative has been made possible by funding from the Dutch Ministry of Health, Welfare and Sport; the Dutch Ministry of Economic Affairs; the University Medical Center Groningen (UMCG the Netherlands); the University of Groningen and the Northern Provinces of the Netherlands.
T235 35418-35564 Sentence denotes The generation and management of GWAS genotype data for the Lifelines Cohort Study was supported by the UMCG Genetics Lifelines Initiative (UGLI).
T236 35565-35708 Sentence denotes JF was supported by NWO Gravitation Netherlands Organ-on-Chip Initiative (024.003.001) and the Netherlands Heart Foundation CVON grant 2018-27.
T237 35709-35855 Sentence denotes MS was supported by EOSC-Life, funded by European Union's Horizon 2020 programme under grant agreement 824087 and NWO-VIDI grant VIDI 917.164.455.
T238 35856-36035 Sentence denotes AZ was supported by ERC Starting Grant 715772, NWO-VIDI grant 016.178.056, the Netherlands Heart Foundation CVON grant 2018-27, and NWO Gravitation grant ExposomeNL (024.004.017).
T239 36037-36059 Sentence denotes Supplementary Material
T240 36060-36217 Sentence denotes The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fgene.2020.00613/full#supplementary-material
T241 36218-36254 Sentence denotes Click here for additional data file.
T242 36255-36291 Sentence denotes Click here for additional data file.
T243 36292-36328 Sentence denotes Click here for additional data file.
T244 36329-36365 Sentence denotes Click here for additional data file.
T245 36366-36512 Sentence denotes Figure S1 Statistical power estimates. (A–D) show statistical power estimates for binary trait analyses, and (E) for quantitative trait analyses.
T246 36513-36741 Sentence denotes In (A–D), each line shows the minimum detectable additive effect size (genotype relative risk, Y-axis) with 80% power and at a significance threshold of 5 × 10−8, for an increasing number of cases in a cohort of 36,339 (X-axis).
T247 36742-36833 Sentence denotes The different lines depict these values when risk allele frequency varies from 0.05 to 0.5.
T248 36834-36921 Sentence denotes The label of the X-axis indicates the disease prevalence (pD) considered in each panel.
T249 36922-37131 Sentence denotes In (E), the line shows the minimum detectable additive effect (variance explained, Y-axis) with 80% power and at a significance threshold of 5 × 10−8, for an increasing number of samples up to 36,339 (X-axis).
T250 37132-37168 Sentence denotes Click here for additional data file.

2_test

Id Subject Object Predicate Lexical cue
32582302-32007143-33453879 2738-2742 32007143 denotes 2020
32582302-31986264-33453880 2758-2762 31986264 denotes 2020
32582302-32007143-33453881 3369-3373 32007143 denotes 2020
32582302-32171076-33453882 3411-3415 32171076 denotes 2020
32582302-32404885-33453883 4414-4418 32404885 denotes 2020
32582302-17767159-33453884 5091-5095 17767159 denotes 2007
32582302-18667698-33453885 5235-5239 18667698 denotes 2008
32582302-18245381-33453886 5253-5257 18245381 denotes 2008
32582302-32142651-33453887 5838-5842 32142651 denotes 2020
32582302-32132184-33453888 5856-5860 32132184 denotes 2020
32582302-32132184-33453889 6165-6169 32132184 denotes 2020
32582302-25502107-33453890 7694-7698 25502107 denotes 2015
32582302-25985141-33453891 9316-9320 25985141 denotes 2015
32582302-30165396-33453892 9472-9476 30165396 denotes 2019
32582302-26432245-33453893 9747-9751 26432245 denotes 2015
32582302-25502107-33453894 10198-10202 25502107 denotes 2015
32582302-27126040-33453895 10796-10800 27126040 denotes 2016
32582302-30250126-33453896 10802-10806 30250126 denotes 2018
32582302-30147377-33453897 11087-11091 30147377 denotes 2018
32582302-28334390-33453898 11604-11608 28334390 denotes 2017
32582302-30104761-33453899 11623-11627 30104761 denotes 2018
32582302-26426971-33453900 13024-13028 26426971 denotes 2015
32582302-29875488-33453901 17642-17646 29875488 denotes 2018
32582302-20634204-33453902 18643-18647 20634204 denotes 2010
32582302-20634204-33453903 19721-19725 20634204 denotes 2010
32582302-15001204-33453904 22576-22580 15001204 denotes 2004
32582302-17887997-33453905 22589-22593 17887997 denotes 2007
32582302-32132184-33453906 25274-25278 32132184 denotes 2020
32582302-32142651-33453907 25369-25373 32142651 denotes 2020
32582302-32196087-33453908 27356-27360 32196087 denotes 2020
32582302-32220865-33453909 27370-27374 32220865 denotes 2020
32582302-32256706-33453910 27392-27396 32256706 denotes 2020
32582302-21832968-33453911 28990-28994 21832968 denotes 2011
32582302-32404885-33453912 32162-32166 32404885 denotes 2020

MyTest

Id Subject Object Predicate Lexical cue
32582302-32007143-33453879 2738-2742 32007143 denotes 2020
32582302-31986264-33453880 2758-2762 31986264 denotes 2020
32582302-32007143-33453881 3369-3373 32007143 denotes 2020
32582302-32171076-33453882 3411-3415 32171076 denotes 2020
32582302-32404885-33453883 4414-4418 32404885 denotes 2020
32582302-17767159-33453884 5091-5095 17767159 denotes 2007
32582302-18667698-33453885 5235-5239 18667698 denotes 2008
32582302-18245381-33453886 5253-5257 18245381 denotes 2008
32582302-32142651-33453887 5838-5842 32142651 denotes 2020
32582302-32132184-33453888 5856-5860 32132184 denotes 2020
32582302-32132184-33453889 6165-6169 32132184 denotes 2020
32582302-25502107-33453890 7694-7698 25502107 denotes 2015
32582302-25985141-33453891 9316-9320 25985141 denotes 2015
32582302-30165396-33453892 9472-9476 30165396 denotes 2019
32582302-26432245-33453893 9747-9751 26432245 denotes 2015
32582302-25502107-33453894 10198-10202 25502107 denotes 2015
32582302-27126040-33453895 10796-10800 27126040 denotes 2016
32582302-30250126-33453896 10802-10806 30250126 denotes 2018
32582302-30147377-33453897 11087-11091 30147377 denotes 2018
32582302-28334390-33453898 11604-11608 28334390 denotes 2017
32582302-30104761-33453899 11623-11627 30104761 denotes 2018
32582302-26426971-33453900 13024-13028 26426971 denotes 2015
32582302-29875488-33453901 17642-17646 29875488 denotes 2018
32582302-20634204-33453902 18643-18647 20634204 denotes 2010
32582302-20634204-33453903 19721-19725 20634204 denotes 2010
32582302-15001204-33453904 22576-22580 15001204 denotes 2004
32582302-17887997-33453905 22589-22593 17887997 denotes 2007
32582302-32132184-33453906 25274-25278 32132184 denotes 2020
32582302-32142651-33453907 25369-25373 32142651 denotes 2020
32582302-32196087-33453908 27356-27360 32196087 denotes 2020
32582302-32220865-33453909 27370-27374 32220865 denotes 2020
32582302-32256706-33453910 27392-27396 32256706 denotes 2020
32582302-21832968-33453911 28990-28994 21832968 denotes 2011
32582302-32404885-33453912 32162-32166 32404885 denotes 2020

PubTator4TogoVar

Id Subject Object Predicate Lexical cue resolved_to
6303 13205-13220 SNP denotes ACE2 rs1726493 tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606
6348 20845-20857 SNP denotes ACE2 rs4646 tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
6333 20207-20216 SNP denotes rs4646190 tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
6337 20442-20451 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
6317 16628-16637 SNP denotes rs5980163 tmVar:rs5980163;VariantGroup:4;CorrespondingGene:660;RS#:5980163;CorrespondingSpecies:9606
6319 16819-16830 SNP denotes rs150965978 tmVar:rs150965978;VariantGroup:7;RS#:150965978
6321 16687-16697 SNP denotes rs17264937 tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606
6322 16866-16876 SNP denotes rs28401567 tmVar:rs28401567;VariantGroup:1;RS#:28401567
6323 16940-16949 SNP denotes rs5980163 tmVar:rs5980163;VariantGroup:4;CorrespondingGene:660;RS#:5980163;CorrespondingSpecies:9606
6364 22172-22181 SNP denotes rs4646190 tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
6367 23075-23084 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
6370 22672-22681 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
6372 23174-23183 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
6418 28815-28824 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
6420 29184-29193 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
6421 29364-29373 SNP denotes rs4646190 tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
6408 27179-27189 SNP denotes rs75833467 tmVar:rs75833467;VariantGroup:6;CorrespondingGene:7113;RS#:75833467;CorrespondingSpecies:9606
6411 27063-27072 SNP denotes rs4646190 tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
6413 26971-26980 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606

PubTatorOnTogoVar

Id Subject Object Predicate Lexical cue resolved_to
6303 13205-13220 SNP denotes ACE2 rs1726493 tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606
6333 20207-20216 SNP denotes rs4646190 tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
6337 20442-20451 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
6317 16628-16637 SNP denotes rs5980163 tmVar:rs5980163;VariantGroup:4;CorrespondingGene:660;RS#:5980163;CorrespondingSpecies:9606
6319 16819-16830 SNP denotes rs150965978 tmVar:rs150965978;VariantGroup:7;RS#:150965978
6321 16687-16697 SNP denotes rs17264937 tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606
6322 16866-16876 SNP denotes rs28401567 tmVar:rs28401567;VariantGroup:1;RS#:28401567
6323 16940-16949 SNP denotes rs5980163 tmVar:rs5980163;VariantGroup:4;CorrespondingGene:660;RS#:5980163;CorrespondingSpecies:9606
6348 20845-20857 SNP denotes ACE2 rs4646 tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
6364 22172-22181 SNP denotes rs4646190 tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
6367 23075-23084 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
6370 22672-22681 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
6372 23174-23183 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
6408 27179-27189 SNP denotes rs75833467 tmVar:rs75833467;VariantGroup:6;CorrespondingGene:7113;RS#:75833467;CorrespondingSpecies:9606
6411 27063-27072 SNP denotes rs4646190 tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
6413 26971-26980 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
6418 28815-28824 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
6420 29184-29193 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
6421 29364-29373 SNP denotes rs4646190 tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
T1 13205-13220 SNP denotes ACE2 rs1726493 tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs5980163;VariantGroup:4;CorrespondingGene:660;RS#:5980163;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs75833467;VariantGroup:6;CorrespondingGene:7113;RS#:75833467;CorrespondingSpecies:9606
T1 20845-20857 SNP denotes ACE2 rs4646 tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs5980163;VariantGroup:4;CorrespondingGene:660;RS#:5980163;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs75833467;VariantGroup:6;CorrespondingGene:7113;RS#:75833467;CorrespondingSpecies:9606
T1 22172-22181 SNP denotes rs4646190 tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs5980163;VariantGroup:4;CorrespondingGene:660;RS#:5980163;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs75833467;VariantGroup:6;CorrespondingGene:7113;RS#:75833467;CorrespondingSpecies:9606
T1 23075-23084 SNP denotes rs4646156 tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs5980163;VariantGroup:4;CorrespondingGene:660;RS#:5980163;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs75833467;VariantGroup:6;CorrespondingGene:7113;RS#:75833467;CorrespondingSpecies:9606
T2 22672-22681 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs150965978;VariantGroup:7;RS#:150965978|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
T3 23174-23183 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
T1 28815-28824 SNP denotes rs4646156 tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs5980163;VariantGroup:4;CorrespondingGene:660;RS#:5980163;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs75833467;VariantGroup:6;CorrespondingGene:7113;RS#:75833467;CorrespondingSpecies:9606
T2 29184-29193 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs150965978;VariantGroup:7;RS#:150965978|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
T3 29364-29373 SNP denotes rs4646190 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
T1 16628-16637 SNP denotes rs5980163 tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs5980163;VariantGroup:4;CorrespondingGene:660;RS#:5980163;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs75833467;VariantGroup:6;CorrespondingGene:7113;RS#:75833467;CorrespondingSpecies:9606
T2 16819-16830 SNP denotes rs150965978 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs150965978;VariantGroup:7;RS#:150965978|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
T3 16687-16697 SNP denotes rs17264937 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606
T4 16866-16876 SNP denotes rs28401567 tmVar:rs28401567;VariantGroup:1;RS#:28401567
T5 16940-16949 SNP denotes rs5980163 tmVar:rs5980163;VariantGroup:4;CorrespondingGene:660;RS#:5980163;CorrespondingSpecies:9606
T1 20207-20216 SNP denotes rs4646190 tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs5980163;VariantGroup:4;CorrespondingGene:660;RS#:5980163;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs75833467;VariantGroup:6;CorrespondingGene:7113;RS#:75833467;CorrespondingSpecies:9606
T2 20442-20451 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs150965978;VariantGroup:7;RS#:150965978|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
T1 27179-27189 SNP denotes rs75833467 tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs5980163;VariantGroup:4;CorrespondingGene:660;RS#:5980163;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs75833467;VariantGroup:6;CorrespondingGene:7113;RS#:75833467;CorrespondingSpecies:9606
T2 27063-27072 SNP denotes rs4646190 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs150965978;VariantGroup:7;RS#:150965978|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606
T3 26971-26980 SNP denotes rs4646156 tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606|tmVar:rs4646190;VariantGroup:8;CorrespondingGene:59272;RS#:4646190;CorrespondingSpecies:9606|tmVar:rs17264937;VariantGroup:2;CorrespondingGene:57393;RS#:17264937;CorrespondingSpecies:9606|tmVar:rs4646156;VariantGroup:3;CorrespondingGene:59272;RS#:4646156;CorrespondingSpecies:9606